Western University

Scholarship@Western
University of Western Ontario Medical Journal

Digitized Special Collections

1993

UWOMJ Volume 63, Number 1, Fall 1993
Western University

Follow this and additional works at: https://ir.lib.uwo.ca/uwomj
Part of the Medicine and Health Sciences Commons
Recommended Citation
Western University, "UWOMJ Volume 63, Number 1, Fall 1993" (1993). University of Western Ontario Medical Journal. 173.
https://ir.lib.uwo.ca/uwomj/173

This Book is brought to you for free and open access by the Digitized Special Collections at Scholarship@Western. It has been accepted for inclusion in
University of Western Ontario Medical Journal by an authorized administrator of Scholarship@Western. For more information, please contact
tadam@uwo.ca, wlswadmin@uwo.ca.

bJished 1930 lume 63 Number 1

TAY
TAYPER
lll."E344D
94-03-07

NOW ELDEPRYL IS INDICATED FOR FIRST LINE THERAPY.
Now you can do more than deal with the disability of Parkinson's disease. You can delay
it with Eldepryl first line. o In newly diagnosed patients. Eldepryl can significantly
retard the worsening of symptoms2.3 and delay the need for levodopa therapy. 2.•.s o In fact.
Eldepryl can delay the onset of disability and thereby prolong functional life by as much
as one yearY o As well. Eldepryl
appears to have a remarkable safety
profile. It has been generally welltolerated with few side effects.•·6•7

o So when you see patients with
Parkinson's disease . prescribe

Eldepryl first line. It's their first
line of defence against the progression of disability.

selegiline hydrochloride
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GUIDELINES
The purpose of the U.W.O. Medical Journal is
to provide a single forum for original a rticles
based on clinical or research medicine of topical or
historic relevance . Since the readership of the
Journal is interdisciplinary, articles published will
attempt to reflect the wide range of medical
disciplines. The Journal will consider empirical,
theoretical, and research reviews. Book reviews
will also be considered. The Journal reserves the
right to refuse articles that do not comply with the
Journal's publication criteria.
MANUSCRIPT SUBMISSIO N: Each submission
mu s t include three (3) copies of the full
manuscript PRIOR TO the submission deadline.
Late submissions will not be accepted for
publication. Authors are expected to submit the
final revised version of the manuscript on 3.5"
computer diskette along with three (3) copies of
the manuscript (the Journal prefers Apple
Macintosh"' Microsoft"' Word or Wordperfect"' 5.1).
All figures must be camera-ready and artwork
must be black and white.
MANUSCRIPT PREPARATIO N: Manus c ripts
submitted should be set with one inch margins
and typed single-spaced. Original research and
review articles should have an abstract that clearly
states the relevance of the article to the medical
discipline being reported on in no more than 150
words. This dimension should be elaborated upon
in the introduction . Original research a r ticles
should have experimental methods, results, and
discussion sections that follow the introduction.
Results and discussion sections may be combined
if appropriate . The discussion section should be
concise and focus primarily on the findings being
pre se nted and their important implications.
Authors should rely on articles or information
publis hed in recognized journals and sources.
References should be listed in numerical order
and within the text in the following format:

TO

AUTHORS

AUTH O RSHIP: All medical students and
members of the Faculty of Medicine of U.W.O. are
invited to submit manuscripts for publication.
Medical students are certainly encouraged to
collaborate with medical staff who specialize in
the medical sub-discipline being reported on.
Manuscripts will also be considered from medical
faculty (including interns and residents) from
universities and medical institutions other than
U.W.O.
M O DES O F C O MMUNICATI O N: Author s
should submit along with their manuscripts a
cover letter including a return address, telephone
number, and fax number (where available) . The
final revised version of the manuscript on 3.5"
computer diskette should be sent (with (3)
photocopies of the manuscript) to:
Th e Editors
U. W.O. M edical Journal
Health Sciences Building;
University of Western Ontario
London, Ontario N6A-5Cl

Proud to support
the U.W.O.
Medical Journal

1. Manev H ., Favaron M ., Guidotti A ., & Costa E.
Delayed increase of Ca ++ influx elicited by
glutamate: role in neuronal death. Malec.
Pharmacal. 36:106-12 (1989).
(With 3 or more authors, either all authors may be
listed or the 1st author followed by et al.)

THE

The Journal reserves the right to edit articles to
correct grammatical or stylistic errors.
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HUMAN IMMUNODEFICIENCY VIRUS-1 (HIV-1)
TRANSMISSIBILITY AND THE LAW
Legal issues related to human immunodeficiency virus-1 (HIV-1) and acquired immunodeficiency syndrome (AIDS)
are evolving more rapidly, perhaps, than any other subject in recent Western law history. Among these issues is the
rela tion of AIDS to the criminal code-specifically disease transmission as an offence. Of particular interest in this
regard is what constitutes an illegal act of disease transmission and what retributive m easures exist for such acts.
Analysis of two cases in which individuals were accused of committing criminal acts related to HIV-1 transmission will
reveal that existing laws are insufficient to deal with AIDS-related legal matters.
Case 1
R. v. Ssenyonga (April 30, 1993), Doc 1560 (Ont. Gen. Div.).1
Offences: Aggravated sexual assault; consent. Accused [of] infec ting complainants with HTV-1.
Decision: Acquitted; courts rejecting arguments of consent, fraud, and public policy.

The accused, knowing he was infec ted with HIV-1 and without telling this to the three complainants, engaged in sexual
interco urse with them, thus exposing them to the risk of HN-1 infec tion, which they subsequently contracted. Th e accused
motioned for a directed verdict of acquittal. This motion was granted based on the ground that each of the three complainants freely
and volun tarily engaged in sexual intercourse with the accused without the use of a condom . The court upheld that although the
complainants may not have consented neither to transmission of HIV-1 , nor even to that risk, the evidence was incontestable that
they did consent to the application of fo rce inherent in the acts of sexual intercourse; this force was not in itself excessive or
dangerous. Furthermore, since the complainants were under absolutely no misapprehension as to the nature of the acts in which
they were engaging, there was no evidence of fraud. Ultimately, since section 265(1)(a) of the criminal code was designed to control
the non-consensual direct or indirect application of force by one person to another, and not to prevent HN-1 transmission among
the body politic, the Crown's public policy arguments could therefore not prevail)
Case 2
R. v. Thornton (August 14, 1989), O.R. (3rd) 480, 42 O.A.C. 206, 3 C. R. (4th) 381 , [1 991] C.C. L. 3659, affi rmed (june 4, 1993),
Doc. 22312 (S.S.C. ).2
Offences: Cau sing bodily harm by criminal negligence. Accused lofl endangering lives of public by kn owingly donating
contaminated blood contributing an unlawful act.
Decision: Convicted; 15 months imprisonment.

The accused was infected with HN-1 and tested positive on two occasions for AIDS. Despite this, he donated blood to the Red
Cross. The accused appealed the decision on the basis that his conduct was not an offence, that it was not proven to have endangered
anyone, and that he lacked the guilty mind. The appeal was rejected. The common law upheld that every person was to refrain fro m
potentially malicious conduct. According to the cou rt, the accused personally knew the danger to which the public was subjected
consequent to his donation of contaminated blood and thus had the requisite guilhj mind. In light of the potential serious hann and
damage to the lives and health of the public, the accused was properly convicted.2
These cases are characterized by similarities and differences-some are obvious and some are not. In both cases,
no twithstanding knowledge of being infected with HIV-1 , the accused engaged in baleful activities. Despite the
parellelism of these acts, one individual was convicted and one w as acquitted . In law, for conviction of a crime to be
maintained, the commission of an offence must contain two components, proven beyond a rea onable doubt. These
components are mens rea (guilty mind) and actus reus (guilty act). In addition, mens rea and actus reus must exist in the
background of the offence charged. Taken alone, each case appears to involve acts with both mens rea and actus reus. But
this is not true when the offences are measured against the charges; this is where weaknesses in the law in relation to
AlDS become punctuated.
o specific legislation which exists is designed to deal with offences related to HIV-1 infection and AIDS. Thus,
such offences must be categorized under existing sections of the criminal code. Ssenyonga was charged with aggravated
sexual assault pertaining to sections 265(1)(a) and subsequently 273 of the criminal code. Section 265(1)(a) states that:
A person commits an assault when without the consent of another person, he applies force intentionally to
that other person directly or indirectly.3

U. W .O. Medica/Journal
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Section 273 of the criminal code states that:
Every one commits an aggravated sexual assault who, in committing a sexual assault, wounds, maims,
disfigures, or endangers the (1) life of the complainant. (2) Every one who commits an aggravated sexual
assault is guilty of an indictable offence and liable to imprisonment for life.3

Under the letter of the law, therefore, the accused was found not guilty of assault and thus of aggravated sexual assault.
Thornton, however, was charged with criminal negligence causing bodily harm pertaining to section 221 of the criminal
code. This section states that:
Every one who by criminal negligence causes bodily harm to another person is guilty of an indictable offence
and liable to imprisonment for a term not exceeding 10 years.3

Thus, the accused was properly convicted. Had Ssenyonga been charged under s.221, he too might have been convicted.
A further example of how existing laws are insufficient to deal with AIDS-related offences is based on retributive
measures. In regard to case 1, the accused was acquitted and thus received no penalty. In regard to case 2, the accused
received 15 months imprisonment; there were no identifiable victims. Had there been any victims, the accused's
sentence may have increased but only to the maximum 10 years. Although AIDS is a fatal disease, it is not immediately
so. Furtheron, although there is a section of the criminal code designed to deal with criminal negligence causing death
(s.220) with a potential liability of life imprisonment, section 227 of the criminal code would likely prevent an AIDSrelated offence from being categorized under s. 220. Section 227 of the criminal code refers to death within one year and
one day:
o person commits culpable homicide or the offence of causing the death of a person by criminal
negligence...unless the death occurs within one year and one day from the time of the occurrence of the last
event by means of which the person caused or contributed to the cause of death.3

Thus, qualifiers such as s.227 preclude existing laws from exacting just punishment.
Thus, within the context of the criminal code as it exists today, current laws are inappropriate and improperly
utilized for unlawfaul acts of HIV-1 transmission. In the cases described, two points are clear. First, the offences
committed are remarkably similar-an individual knowingly infected with HIV-1 transmitted or attempted to transmit
the disease, or risk thereof, to innocent, unassuming people. Second, neither section of the criminal code under which
the accused individuals' were charged appear sufficiently equipped to provide for due course of law. In case 1, the
accused was charged with aggravated sexual assault, possibly because of the potential maximum penalty of life
imprisonment, but the charge was inappropriate for the offence. In case 2, the accused was charged with causing bodily
harm, not death, by criminal negligence; the charge was bodily harm perhaps because of the potential leniency of the
penalty, and because although AIDS is fatal, it isn't immediately so (at least not within one year and one day).
Clearly, the capability to transmit HIV-1 infection represents a danger to health and life. Conspicuous by its absence
is a specific set of laws designed to accommodate AIDS-related offences, especially the unlawful commission of HIV-1
transmission. These laws will have to strike a balance between the civil rights of the HIV-1-infected population and the
uninfected population-a difficult task since the AIDS population already suffers from discrimination and is unlikely to
seek testing or help from public agencies unless reassured that they will be neither further ostracized nor have liberties
removed.
I would like to thank Ross and Anne and the entire Journal staff for helping to produce this fine issue, which
features infectious diseases. Be sure to read Stitches In Time- it's guaranteed to make you smile. And please take a
moment to read A Note to Our Readers on page 10. Enjoy!

Jeffrey rrolitsky, :Meds '9 4
rulitor-1 n-Cfiief
1 Canadian Current Law. July 30, number 7 (1993). Case Law Digest 6998.
2 Canadian Current Law. July 30, number 7 (1993). Case Law Digest 7000.
3 Criminal Code of Canada. R.S.C. 1993.
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Inequities Of Gender Discrimination
Recently I attended a continuing medical education
conference entitled "Gender Inequities in the
Classroom ." The objective of this conference was to
increase awareness of gender discrimination. However,
the ensuing discussion used exaggerated examples of
gender differences in a futile attempt to explore the
issue of gender discrimination . These examples
included issues such as the ratio of female to male
medical school admission applications and alcohol
consumption patterns at all-female parties. I was
angered by these ridiculous examples and the overt
discrimination created by a discussion of gender
differences.
Gender discrimination refers to the ability to
distinguish between men and women. This 'rightful '
form of discrimination involves acknowledgment of the
basic features that distinguish both sexes. Gender
discrimination may also be defined as unfair treatment
based on a person's gender. The prejudicial basis of this
latter form of discrimination makes it 'wrongful'. This
'wrongful ' form of discrimination deserves attention
and analysis in an effort to reduce its prevalence in
society.

Acknowledging basic features that distinguish one
gender from another may create greater acceptance and
understanding among men and women . Attempts to
magnify these differences, however, will serve only to
further alienate members of each gender from one
another. For example, an all-female party organized to
rall y s upport against overt gender discrimination
merely perpetuates it by intentionally excluding one sex
from such an event.
A large proportion of efforts to reduce the incidence
of ' wrongful' discrimination find ba sis with the
apparently trivial differences between men and women.
Yet men and women do not adopt the same societal roles
and should be treated differently accordingly. Essential to
the continued effort to decrease 'wrongful' discrimination
is the confirmation that 'wrongful' discrimination stems
from prejudice and dislike, not anatomical and societal
characteristics. The continual analysis of the basic gender
differences between men and women will trivialize the
entire effort to eliminate 'wrongful' discrimination and
will ultimately pit the sexes against each other ad
nauseum.

!Anne Silas , Meds •94
!Associate 'Editor

Business Quarterly and The UWO Medical Journal:
Are We Poor Cousins?
I learned a few weeks ago that The University of
Western Ontario Business School publishes an extremely
well respected and well known serial, Business Quarterly
(BQ). The status of BQ in the field of business management may be comparable to that of the New England
Journal in the field of Medicine. BQ is edited by a retired
business professor on a part time contract and employs a
full time staff of two.
The original Business School journal was started in
1932, and was managed entirely by students. The earliest
copies of The UWO Medical Journal (UWOMJ) also date
from about that time. A major difference between the two
publications is that the UWOMJ is still managed by
students. BQ is an ancillary unit of the University, like
Food Services and the Book Store, while the UWOMJ is a
subaccount of the Hippocratic Council. BQ's yearly
budget is about one million dollars; that of the UWOMJ is
around $20,000. BQ has a subscription circulation of
about 10,000 at a cost of $39 per year; the UWOMJ has a
circulation of approximately 2000 and a subscription fee
of $17 per year, however, most of the readers are
unfortunately not subscribers. Further, BQ represents a
professional business school whose reputation is among
the best in North America, established, in part, on the
strength of the popularity and esteem of their serial. On

the other hand, UWOMJ represents a professional school
whose reputation is possibly the best in Ontario.
The difference in the historical development of the
two publications has been the degree of faculty
involvement. From the beginning, BQ has operated with
support from Faculty members in the form of an advisory
council, and subsequently, a consulting editor.
Eventually the Dean of the School took financial
responsibility for the publication and, only five years ago,
appointed the present Editor, who accepted the challenge
of making BQ self-supporting . The UWO Medical
Journal, meanwhile, has carried on with a new Editor
every few years and consequently a new vision, a new
quality ethic and a new policy, for better or for worse. We
need a wider subscription base, a greater sense of pride
and greater Faculty involvement, including the Dean's
Office. If the experience of our cousins at the School of
Business is any indication, this is one opportunity the
School of Medicine can't afford to pass up.

~oss

Mantel, Meds '95
!Associate 'E.ditor
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e UW O :Medical Journal is
rrently in its Gyd year of
publication . 'Tfie Joumal fias
undergone many cfianges over tfie past
62 years-some for beHer, some for
worse. 1Juring tfie first 45 years or
so , tfie Journal was strong and
consistently good ; during tfie
subsequent IS years , tfie Jo urnal
suffered from a decline in interest,
faculty support , and consequently
quality. 'Tfiis declin e was truly
unfortunate.
'Tfie University of Western
Ontario 'Faculty of :Medicine is fiigfily
respected, nationwide and beyond, for
a variety of reasons . 'ffiese reasons
include undergraduate and graduate
medical education , clinical practice,
and scientific researcfi. '10 tfiose of us
wfio are involved witfi tfie Jo urnal, tfie
UWO :Medical Journal sfiould be
anotfier unique aspect of tfie University
of Western Ontario 'Faculty of
:Medicine wfiicfi stands out and
adequately parallels tfie otfier efforts of
tfie 'Faculty. Since September I99 I ,
tfie Jo urnal fias progressed toward tfiis
goal.
'Tfiis is now tfie tfiird consecutive
year tfiat tfie Journal fias experienced
improvements and increased interest.
One need merely to loofi. at tfie Jo urnal
to appreciate its attractive appearance.
'Tfie body of tfie Jo urnal is similarity
better as well, witfi a feature section for
eacfi issue, and a more diverse range of
topics , including 'Faculty :News ,
general articles , fiumour, and
education. 'ffie Jo urnal fia s also
improved in ways tfiat aren 't so
obviou s-an excellent publisfiing
company, guaranteed income from
advertising , and many fiou rs from a
fiard-worli.i~j] J ournal staff. (See
'Editorial Staff, page J )
Yrn ancillary component of tfie
'Editorial Staff is tfie Yrdvisory Council.
•Tfie Council, wfiicfi is composed of
botfi 'Faculty members and medical
10

students, was designed and created just
over one year ago in order to ensure tfie
maintenance of Journal quality over
time. 'Tfie creation of tfie Council was a
large step forward for tfie Journal.
'Faculty support of tfie Jo urnal fias
come not only tfirough tfie formation of
tfie Yrdvisory Council, but tfirougfi
subscriptions as well. 'ffie income
generated tfirougfi advertising accounts
for a large percentage of Journal
expenses-b ut not all! So , in an
aHempt to generate jurtfier revenue, tfie
Journal staff and Yrdvisory Council
decided to initiate a subscription drive
targeting 'Faculty members. 'Tfiere
fiave been many positive responders, a
few negative responders, and a large
number of non-responders.
Some readers fiav e sfiown
resentment toward tfie subscription
drive eitfier for fiaving been asfi.ed to
pay a fee fo r sometfiin,9 tfiat was never
requested, or for merely being botfiered.
'ffie Journal sincerely regrets any illwill generate d because of tfie
subscription drive.
'ffie Journa l is asli.ing 'Faculty
members to sfiow tfieir committment to

tfie Journal in tfie form of a I?
subscription because we believe tfiat tfie
current Journal is sometfiing tfie
'Faculty of :Medicine can not only be
proud of, but can benefit from as well.
Yrnd we fiope we can count on your
support in tfiis manner. '10 demonstrate
our committment to tfie 'Faculty, tfie
Journal will continue to send copies to
all 'Faculty members. 'Tfie Jo umal
believes tfiat, after you fiave read tfiis
issue, you will agree tfiat tfie Journal is
a very wortfiwfiile cause to support and
tfiat you will want to be part of our
growtfi.
'ffianfi. you for your understanding
and your support. Witfi best regards,
Jeffrey rpo[itsfi.y, 'Editor-ln-Cfiief
!Anne Silas,Yrssoc. 'Editor
'Ross :Mantle, :Assoc. 'Editor
rp_s. 'Tfie Jour nal's "'Friends &
rpatrons " list is on page I I. ''Friends '
are tfiose wfio fiave subscribed to tfie
Journal; ·rpatrons' fiave subcribed and
made ( tax deductible ) cfiaritable
donations (of 20 or more ) to tfie
Jo urnal.

R uired

R~ding

throughout
your career
For subscription
information
call:(416) 596-5981
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DEAN ' S CORNER:
NEW

FACILITIES FOR THE
PART I I EXAM

L.M.C.C.

By Jim Silcox, M.D., Meds '67
Assistant Dean, Student & Faculty Affairs.
f you have had a chance to drop in
on the new Learning Resource
Centre lately you may have noticed
a little office off the main lobby that is a
beehive of activity. It is our new
standardized patient office. Thanks to
startup funding from the Medical
Council of Canada, we have been able
to hire Linda Ladner as the coordinator for this new teaching
resource. She is currently involved in
our first big standardized patient
project which will be the Part ll exam
of the Medical Council.
As most trainees know, in order to
get a Licensure of the Medical Council
of Canada (L.M.C.C.), candidates must
pass Part I of the Medical Council of
Canada Qualifying Exam at the end of
Medical School, complete a year of
post graduate clinical training, and
then successfully complete part ll of
the exam. The first run of the Part ll
was last year in Calgary and Toronto
(although pilots had been run before
that) . This year, since more provinces
require the new L.M.C.C. credential,
more centres will be running the exam.
We will be joining six other sites,
U.B.C., U. of Calgary, U. of Ottawa, U.
of Toronto, Sherbrooke, and Dalhousie,
to run the exam simultaneously on the
weekend of October 30 and 31.
The exam is in the objective
structured clinical evaluation (O.S.C.E.)
format. It will be composed of ten, tenminute patient stations and ten couplet
stations. The couplet stations will be
composed of a five minute patient
"encounter" followed by a five minute
question response time called a "post
encounter probe" or ''PEP'' station for
short. Each of the patient stations will
have a trained, standardized, patient
programmed with a story or set of
signs and symptoms. The candidates
will have a "hint" as to the patient's
problems prior to entering the room
but will have to carry on from there in
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the allotted time. An examiner will sit
in each room as well and macl< the
candidate on her or his performance.
When the buzzer sounds, the encounter
must stop and the trainee moves to the
next room in the style of the old ''bell
ringer" exams that most of us
remember from Meds and preMeds.
Linda's job is to recruit and train
the patients according to the contract
laid down by the Medical Council.
This means "auditioning", then
assigning cases appropriately (you
can't have healthy 22-year-olds playing
asthmatic senior citizens), and then
coaching and rehearsing and refining
their role playing till it truly becomes
standardized. Station number six must
look exactly the same to a candidate in
London, as it looked to a candidate in
Vancouver or Halifax. We have had
excellent cooperation from people from
all walks of life for this project and
many have had experience in amateur
theatre so their portrayals should be
very lifelike.
As you might imagine, security for
such an exam is important. The exam
takes four and a half hours (including a
half hour intermission) and runs twice
over on Saturday and twice on Sunday
so a total of four cohorts of forty each
can "write" here in London. The
Saturday morning exam and afternoon
exam are identical but the afternoon
cohort will register and be closeted
before the morning group are finished
so there should be no communication
between the groups. The Sunday
exam is a different exam but equivalent
in terms of difficulty. You might think
that the time zone differences might
prove to be a security problem,
however, by the time the Dalhousie
morning group get out of the exam the
Vancouver afternoon group will
already have gone in. The large
number
of
examiners
and
standardized patients involved are all

sworn to secrecy as well.
If Linda looks a bit frazzled the
week of the exam bear with her. The
logistics of getting our groups of
candidates, physician examiners, and
standardized patients parked,
registered, fed, watered, deregistered
and finally out of the building will rival
the efforts of Cecil B. deMille when he
filmed his mob scenes for the Ten
Commandments. Nevertheless, as of
this writing all is going well We have
a specialized site staff of about twenty,
plus the resources and amenities of St.
Joseph's Health Centre to thank for the
smooth progress to date.
Within ten days of the Part II
exam, Linda will be at it again, helping
Dr. Rieder run another O.S.C.E. for the
exit exam of the clerkship. She will
have little time to rest on her laurels!
In fact, now that she is established, it is
our hope that departments will use her
services more and more as time goes
by. Teaching in a Problem Based
Learning format or in Clinical Methods
can be significantly enhanced if there is
a patient for students to work with.
We envision the day when course
coordinators will be able to call her and
"order" patients with certain
programmed signs and symptoms for
use in a teaching clinic for a specified
time and place. This "off the shelf"
approach could have applications in all
Health Science faculties, and indeed in
other programs like social work and
education. In time her office and
position can evolve into a faculty wide
resource . Visionaries have even
suggested that this service could
extend into the community where we
might help agencies like the Police or
Fire Departments train personnel to
deal with the public. If we sound
excited and enthusiastic it is because
we are! Drop in sometime when you
are in the Learning Resource Centre to
n
see how things are going.
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THE S.A.P. REPORT
by Anne Silas, Justin Amann,
& Jeffrey Politsky
JP:Well guys, clerkship is nearly
over. In fact, by the time our trusty
fans read this report we'll each be
off in our own elective world.
JA (beginning to sing): Look's like
we made it, .. .
AS (cringing): Uggh. Just cuz
you're tall doesn't give you the right
to sing.
JA: Alright then, ye of one foot
below, let us peruse our minds for
remna nts of clerkship experiences
gone by.
AS: Failing that, we'll just make it
up! Jeff, you're up-what's your
personal best?
JP: Well, there' s actually two. But I'll
tell the second one as a nice segue
into Debbie P's most ernbarassing
moment.
JA: So then, tell us.
JP: 'Twas a dreary, solemn night.
The wind howled at the moon
(ea rlier in the day the sun also
howled at the moon). Sharp cracks
of rain were whipped against the
hospi tal
windows
with
a
tremendous thrust.
AS: Good Grief. What a shrnooze.
JP (ignoring A.S.-he's good at that
now): The chief surgical resident
handed me the pager- my very first
time. Boy, I thought (my thoughts
were shallow)! I'm not just a clerk
anymore, now I'm a clerk with a
pager! Not soon after, I received my
first call:
'Mr. H. has a fever of 38.7. He's
6 hours post-op,' the nurse said.
'Hmmrn,' I answered (it was all
I could think oO. 1 just thought
I'd let you know,' she stated. 'Of
course, thank you ,' I replied
quickly, and hung up.
-FEVE R , FEVER-OMEGOD FEVER. What do I do? Look up th e
ca uses-too many- holy s_-now
what? I know, I'll get a doctor, a real
one, someone with knowledge- grey
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hair, stethoscope, and an unstained lab
coa t . Wh ere do cto r? Wh ere doctor?
Hmmm , the O.R., that's it, after all, the
poor sod's post-op. Look, there's Dr .
Wood , he likes me(??).
'Dr. Wood, Dr. Wood,' I cried.
'Oh hi Jeff, how are you?' 'Dr.
Wood? I need a Dr .' ' Well ,
what's wrong Jeff?' he said
soothingly. ' I just got my first
page-a patient has a fever38.7!!' I exclaimed . 'Oh dear,' he
said with a grin, 'what do you
think caused it?' he asked.
THINK? THINK! NOW?! Can't think,
brain gone, Ug, Ug.
'I'm not sure Dr. Wood, but he
just had an operation,' I
answered. 'Hrnrnrn. Well Jeff,
what does the patient look like,
is he in pain?'
PATIENT? LOOK LIKE? PAIN?
Ohhhh! The Patient! I should examine
the patient! You stooopid idiot! You
forgot to see the patient!
'The patient was vague, sir, but
I'll go back and get the straight
goods,' I mana ged to squeak
out . 'Good thinking Jeff, and
don ' t forget to rule out the
causes of post-op fever. If you're
still unsure, consider talking to
the surgeon (why bother me,
clerk!), he said reassuringly.
Post-op fever! So that's it.
I then proceeded back up to 4 NW
after reading some text, examined
the patient, and informed the nurse
that this patient's temperature
would likely dissipate over time
and respond to some tylenol. About
two hours later, I got another call
from the same floor about the same
patient:
'Mr. H . is in pain, his wound
has broken open, what should
we do?' the nurse asked.
OPEN?! He's dehisced? ! OMEGODDo ctor , Get a Do ctor . I know , Dr.
Wood ...
JA: What a horrible experience! Is
Dr. Wood okay?
JP:Very funny . How ' bout you
Anne?
AS: Moi? Well, one of my worst
experiences carne on a quiet day in
the Paeds ernerg. I was working

with Jeff P. and Dr. Reider-they
were both looking for someone to
bug, I mean something to do. I was
filing my nails when, suddenly, I
got a phone call. It was a guy named
Dan, a lonely respiratory therapist
working at the south street campus.
He said he remembered me from
my surgery rotation.
'Hi! It's Dan! 'Member me?' he
asked . ' No! ' I replied . ' I'm a
respiratory therapist; I'm at
so uth s treet . Are you busy? '
'Yep! ' I answered, not wanting
to prolong thi s. ' Oh! Well , I
thought maybe we might get
together; I could come over
there if you want-we could
brea the into the same bag.' he
so unded pathetic . ' Gee, Dan,
I' m awfully bus y right now
(yea h, right!!); this isn' t a good
time for me .' I so unded off.
there 's
always
' Okay,
tomorrow-is Jackie there?'
I then proceeded to recount the
conversation to Jeff . Jeff then
announced to Dr. Reider that Dan,
the respiratory man, had just asked
me, Anne, out for breakfast, to share
two scoops of raisins in a package of
Kellogg's Raisin Bran . That' s all I
heard for the rest of the afternoonDan and Anne and two scoops of
rai sins in a package of Kellogg's
Raisin Bran.
JP (smiling & bl o cking h is
privates): Sorry, we were bored. But
tell me, how did the date end?
AS: Swine! Okay, Justin, you're
turn.
JA: Actually, rather than dispel
rumours of my upright and
steadfast performance during
clerkship, I prefer to live vicariously
and tell about other peoples'
blunders and mishaps.
JP: Fine with us Justin! Why don' t
you regail us with the yarn about
Debbie and Dr. Maxwell's crotch? I
think I've told it to you in sufficient
detail.
JA: Indeed! This will be a pleasure.
As the story goes, it was a Friday
before Chistrnas, late in the
afternoon. Dr. Maxwell, decked in
surgical greens, was lecturing to a
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group of surgery clerks about
dissecting aneurysms. I believe, Jeff,
that you were one of those clerks.
JP: Oui! C' est vrai.
JA: As the lecture progressed,
Debbie' s neck began to feel sore. We
know this to be true because her
head was reposed downward , at a
rather peculiar angle, obviously to
gain relief from the pain she was
feeling (heaven forbid that it may be
another, less virtuous, reason). Little
did Deb know (???), though, that
her positioning was distracting the
grand puba. After 5 minutes, or so,
Dr. Maxwell finally spoke up :
'(Looking down at his unit) Excuse
me, Debbie, but is there something
wrong with my crotch, because you
can' t seem to take your eyes off of
it! ' Poor Deb, she was beet redlaughter was hard-absolute
hysteria for at least 10 minutes .
Anyway, just thought we'd record
this for Deb's sake. Nobody really
knows why she was staring at him
that way.
JP: Sounds suspiscious.
AS: Even more suspiscious is the
clerk who sold his soul by paying to
be off call. 'Nough said.
JA: We can't forget about Ken and
Harry. On surgery, Ken' s resident
accidently set a patient on fire,
which Ken promptly put out. Then,
clerk Ken got chastized for
contaminating the sterile field. And
good ol' Harry. He'll be a researcher
I tell you.
AS: Whadya mean?
JA: Harr y wanted to know if
naloxone really is an opiate
antagonist. So, he found a patient
who was particularly morphinesensitive for his study. He then gave
him just the right dosage of
morphine! He followed this with
some Narcan (that's thinking on
your feet!) and successfully reversed
the morphine effect. Now, he ' s
known in medical circles as 'the
narc.'
AS: Please, let us not forget the
story of the clerk and the wrong
orifice . One day on an emerg
rotation, a green clerk was sent in to
a female patients' room, a . k.a .
' young Dr. _____ , ' as he was
introduced by the resident. 'Dr.
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_ _ is going to do a rectal exam in

order to feel your mass; go ahead
Dr.' After a couple of minutes, our
young clerk/Or. looked up and said
to the resident, 'I'm sorry, I can't
seem to palpate the mass.' The
patient q uickly intervened at this
point, ' Perhaps that's because
you're not in my rectum!! ' The
resident then left the room, since he
couldn't control his laughter in
public.
JP: Poor chap. Oh well, that's all we
have to say this time 'round. Look
out for the final S.A.P. Report ever,
in the next issue. For those of you
who are wondering, yes, the JJ
Report is no more; the new model
(the S.A .P. Report) is apparently
50% more invasive.
Q

Me

ds

I

9 5

by Jamie McNabb
hat to say, what to say,
what to say? I guess we
could
welcome
one
another back from summer
vacation, but by the time this has
gone to press, that little formality
will hav e taken care of itself ad
nauseum. So, let's just forget that
one, shall we? I think it would be
better if I just forged ahead and
relayed all the juicy little tid-bits
that have been cooked up over the
first couple of months of 3rd year.
Well, nothing has happened. Zip.
Zero. Nada. Alright, there were a
couple of pubs, Ocktoberfest, maybe
a few private get togethers of 6 or 8
people eating spinach dip and
exchanging gossip, but there didn't
seem to be any one big blow-out
where eve ryone got together and
whooped it up as a class. Maybe
that's what this space in the Journal
should address this time around.
The more I think about this, the
more I've seen it coming. It is not a
phenomenon that has reared its
ugly head just for our class alone.
We're not, as a group, such bad
folks that we should be singled out
for such a fate. I'm sure it happens
to every class at some point along

W

the line, and I guess now it' s our
tum.
We ' re not the Class of ' 95
anymore . I think it' s more
appropriate that we be called "the
Multiple Sub-Classes of '95." We' ve
all found those around us with
whom we feel most comfortable .
These are the ones we call when we
want to go out, or hang out with
when we want company. I guess it' s
only natural. But inherent in this
segregatory process is the fact that
not only do we choose who we want
to be with, but we also identify
those we want to be without.
Remember the first da y of
Medicine when we were all milling
about outside AuditoriumA,
tempering our own excitement with
the awkward nature of being
thrown together with a bunch of
near total strangers? I guess this
whole process started then; how,
I'm not so sure. Maybe it was the
way we looked ("Will you look at
the nose on that guy?") or how we
dressed ("Can you believe it' s after
Labour Day and she's still wearing
white?"), but no matter, we were all
doing it. We liked certain things
about some, and disliked things
about others, allowing only a few
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excha nges between the "in" and the
"out" piles.
Don' t get me wrong. I don' t think
that we should start looking now for
a ninety-six bedroom bungalow with
a lovely back ya rd on a major bus
route so we ca n all live as one big
happy family, that' unrealistic. After
all, most leases don' t come up until
April o r May. I also don' t think we
should get together once a month at
a pre-arranged time and place for a
group hu g . But ma y be we co uld
remember once in a while that, like
it or not, we are all linked by a
common bond -we're the ones who
will g raduate as physicians in 1995,
come hell or high water. All of us
face si mil a r obstacles, especially in
thi , our clerkship year, and we all
have to get by them . On that basis
alone we ha ve more in common than
we might at first have thought.
So w hen you ' re going about your
bu iness thi s yea r, and you're just
fini hing a day where you've felt like
a com pl ete fool eve ry tim e yo u
offered an answer, and you pass by
one of your classmates on your way
to Kavorkian's office, s top a nd
chat ... briefly. Maybe we' ll find that
the "Out" pile is a little smaller than
we once thought.
Q
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H

ere We Go Again

Welcome back. I hope everyone
had a fabulous s ummer and is
refreshed, recharged and ready to
learn. It sure is nice not to be known
as the " first yea rs " an y more .
Speaking of firs t year, ours ended
with a blast. As the rest of U.W.O.
was leaving for home, Med s '96
(having a couple more months to go)
brought in the summer with a "hottub" party at Kirk's. With that out of
our sys tem , we bared down for
exa m s . Finally, the interminable
Phase I ended, and we bid adieu at
the bar-b-que and piflata party hosted
by Drs . Anderson and Garcia . The
revelry began again with the first
week of September, as sleepy-eyed

memb e r s of M ed '97 (a nd a few
dedicated Meds '96ers) fo und their
way to the UH patio for w hat was to
be the mother of all orientation weeks.
Congratulations to Tara and Marcie,
who certainly outdid themselves in
running such a great orientation that
all of us wished that we were in first
year again (Well, maybe not. But they
were pretty dam do e). I don' t know,
but Fanshawe will never be the same
now that we actually all know each
other- not that it stopped u from
showing Meds '97 how to party.
Anyway, good luck to all in the
new yea r, and a special welcome to
Meds '97. Remember, if we could do
it, so can you.
P.S. Con gratulations to Lisa
Klassen (nee Rupke) on her marriage
and to Mike Hor ey, Joe Kim, a nd
Steve Gallant on their engagements
this summer.
n
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by Angelo Mikrogianakis,
Heather McMulkin , and ]apheth Noah
cce pt th em and t h ey will
come .. .. Accept them and they
will come." The ghostly voice
haunted the Admissions Committee
continuously. What could it mean?
Wh y co uld only they hear it? The
entire group had become confused
and frightened.
The voices became louder and
more persis tent as the hot d ays of
summer began. On July 9th the voices
reached a deafening crescendo. Then,
suddenly, the y disappeared as
quickly and mysteriously as they had
begun . There was no ex planation,
everyone wa s just happy it had
ended.
Beginning on July 11th, the joy
and celebration sprea d through
certain homes across the country .
Plans were mad e, suitcases packed,
transportation
a rran ge d
and
accommodations reserved. In early
September the migration began .
Ninety-six people were on their way
to London and U.W.O .. They did not
know what awaited them there or
what the future would bring.
It was not until the morning
hours of September 8th that both their
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and th e Admissions Committee's
questions were answered. They had
all come in search of a dream!. .. to
form the "Class of Dreams", U.W.O.
Meds '97.
The theme of thi s yea r '
orientation was particularly inviting,
"Go hard ... or go home." The Dean's
BBQ was a relaxing way to spend our
first evenin g toge ther. Some of th e
most common phrases heard were:
"You're from New Brunswick too! ?",
"Which one is Angelo?" , "Why did
they give us RED hats?", and "I'm o
glad that I d o n 't ha ve to cook
tonight" . An interesting event some of
us attended wa the Western vs
Guelph football game. We had to
wear our Meds '97 T-shirts and hats
to get in . Our s u gges tion to next
year's orientation committee is not to
give out red and white hats to new
s tud ent when Wes tern is playing
Guelph becau se tho se are Guelph
University football colours! Yes, we
were cool.
Apparently our class consists of
38 females, 56 mal es and two cross
dresser ! At the Fanshawe Park picnic
we had a large turnout but were
un able to get e nough gi rls to
participate in the traditional "boat
race". Luckily, Mike and Angelo/lina
quickly volunteered to take the girls'
places a nd willingly donned bra s,
makeup and creative new hair style .
Med ' 97 maintained s u ch a high
part y a tmo s phere throughout
September that the entire class lost
their body defense mechanisms and
got the flu! Since we have classmates
from Toronto, Ottawa, Montreal,
Fredericton, Halifax, London, rural
Alberta and Vancouver, the origin of
thi s flu is an epidemiologist's
nightmare!
During preceptor day some of us
were initiated in various fields of
medicine and a few of us got to
appreciate our own ignorance in
surgery.
In essence, the orientation was
memorable, the Faculty was great and
most importantly, Meds '96 deserves
to be commended for their excellent
work. Thanks also to the upper year
classes, whose orientation expertise
was probably transduced from Meds
' 94 through '95 to Meds '96 via
neuromuscular or gap junctions.
Q
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HIPPOCRATIC
WHAT'S BEEN
THE REST OF

COUNCIL

HAPPENING IN ONTARIO,
CANADA AND BEYOND .••
by Ambrose Au, Meds '95, V.P. External.

his past year has seen much
activity within the health care
forum resulting from changes
in government policies and
agendas.

T

Social Contract
By now, most people are familiar
with the Ontario government' s
social contract talks which were
directed at deficit reduction. When
the dust settled in August, the
OMA
and
the
provincial
government signed and ratified an
interim agreement that will last
until early 1996. Based on this
agreement, total OHIP expenditures
will be reduced over a three-year
term. Expenditures in excess of the
limit will be the responsibility of
the profession. The government
has already taken steps to reduce
overall expenditures (tightening
eligibility criteria for health
insurance ) . The OMA has also
recently advised physicians to
reduce their individual billings by
5% for the current fiscal year. This
is in an attempt to prevent the need
for "clawbacks." In addition, OHIP
will be holding back 4 .8 % of
billings which will be returned to
those physicians who at the end of
their fiscal year, are successful at
reducing billings.
In an attempt to improve
physician resource management,
physician supply will be stabilized
over the next three years. During
this period, out-of-province
physicians without formal Ontario
medical training will not be eligible
to bill OHIP for services. In
addition, International Medical
Graduates wishing to be licensed in
Ontario will require certification
(by the CFPC or RCPSC) as well as
at lea s t one year of Ontario
postgraduate training. Certification of all new Ontario graduates
will continue to be the prerequisite
to licensure. The government has
16

promised to develop further plans
to promote voluntary retirement
and
to enhance physician
distribution to underserviced areas.
Many other initiatives are being
developed to improve physician
resource management.
In addition, a number of
management changes are being
initiated to address issues such as
health-card
fraud,
public
education, delisting, and thirdparty services.l
O ther Ontario Business
The Clinical Clerkship stipend,
once a part of the Ministry of
Health's Clinical Education Budget,
has been formally eliminated. Only
those students who are currently
completing their clinical clerkship
will be entitled to a smaller
percentage of the original stipend.
The
Council
of
Ontario
Universities released a discussion
paper in August. This paper
proposed increases of 30 % to
tuition by 1995-96 in most
undergraduate programs. As well,
second-entry professional programs, such as medicine and law
are to h a ve tuition realigned to
double the rate for undergraduate
arts and science students. The
rational e for the latter include
proportionally smaller tuition fee
contributions to total costs of
programs such as medicine and
dentistry, as well as the potential
earnings of graduates from such
programs.
U.S. Training Visas
Studen ts who are interested in
completing their residency training
south of the border should know
that the doors are closing rapidly.
In order to receive a }1-VISA
required for training, students
require sponsorship letters from
the government of Canada. Such a

letter will be granted to medical
graduates only for the following
reasons: if the province in which
the candidate intends to seek
licensure can show that the training
is consistent with the province's
existing physician resource plan; if
the candidate has obtained prearranged employment or return-inservice commitment in Canada; or
if the candidate is licensed and
undertaking further clinical
training in his field of practice .
Under Ontario's current physician
resource management plan ,
graduates are u nable to seek
training in the U.S.
The alternative H-1B-VISA for
postgraduate training requires all
candidates to have passed all three
steps of the USMLE. This visa is
currently under review in the U.S.
Sources indicate that this visa will
in all likelihood not be offered in
the near-future.
Postgraduate Training
Following last year's CIMS match
surprise in which 96 Canadian
graduates were left unmatched
(double that of the previous year),
postgraduate deans and program
directors were left scrambling to
avoid repeating this disastrous
outcome once-more. At this point,
the
National
Coordinating
Committee on Postgraduate
Medical Training is maintaining its
recommendation that all Canadian
medical graduates be guaranteed
postgraduate training . Unfortunately, some Provincial Deputy
Ministers of Health have indicated
that they may not be able to fund
sufficient entry level positions to
cover the size of the graduating
class . Plans to restrict access of
International Medical Graduates to
postgraduate training have been
discussed as have plans to ensure
that students funded through the
Department of National Defense do
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not take up spaces fu nd ed by the
Ministry of Health. The results of
these initiatives is yet to be seen.
On a more positive n o te, CIMS
has agreed to set up a PGYI /PGY2
registry in which residents wishing
to transfer to othe r training
programs may enter a central
registry which will help them trade
programs with other residents. The
process will remain confidential
until a match is made at which time
the program directors will be
notified and given the choice of
accepting or declini n g such an
exchange.
The provinces are currently
investigating the use of training
cards as a mechanism of funding
postgraduate trainees. Traditionally, the Ministries of Health
have allocated funding d irectly to
postgraduate training positions.
A a result, st u dents could only
apply to positions which received
government funding. Under the
proposed changes, the funding
would be directed towards the
postgraduate trainee h imself/herself. Each graduate would then
receive a training card which

would guarantee the holder full
funding for training for the
du r ation of their program. This
would red u ce the number of
funded but vacant po itions (e.g.
anatomical pathology) and make
tracking of expenditures easier for
the Ministries of Health. Other
issues concerning training cards are
currently being evaluated by the
provinces.

News

po tgraduate training in the U.S.,
and rural medicine among other
issues . The CFMS continues to
participate in many national forums
which direct policy decision.
References
1. Synopsis of the O M A/Gov' t 1993 Interim
Econom ic Agreement. Ontario Med. Rev. 60
(8):15-20 (1993) .

CFMS Annual Meeting
Thirty-six delegates met on
October 1-3 in St. John' ,
Newfoundland to participate in the
13th Annu al General Meeting of the
Canadian Federation of Medical
Students (CFMS). The CFMS
represents over 5500 Canadian
Medical Students attending all 13
anglophone medical schools across
the country .
Reports were
presented from all the participating
schools as well as from the four
regional directors . Discussions
centered around postgraduate
prelicensu re training (acceleration
of career decision making, access,
portability, and MCCQE Pt II),

This year, UWO sent three delegates
to the CFMS-AGM: Lesley Horton Meds ' 94 (Ontario Director) ,
Ambrose Au - Meds '95 (Sr. Rep) ,
and Elin Ringstrom - Meds '96 (Jr.
Rep). We will continue to represent
UWO medical students to the
Canadian and Ontario Federations
by mean of regular meetings,
information and feedback sessions,
and active lobbying. Please do not
he itate to contact any of us with
your concerns or interests.
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I n Search of the Clock:
lnvesti gating the Re l ations of
Senescence
and Circadian Rhythmicity
by Ross Mantle , BSc, Meds '95.

ABSTRACT
ecent advances on
th e decay of
c ir c adian
rhythmicity as part of
th e mechanis m of
mammalian senescence
are explored . Appropriat e historical and
sc ientif ic ba ckg round
information is provided
along with con cepts of
ex perim enation and
intervention .

R

INTRODUCTION
Humanity is a tool-making species, conditioned by
the constant presence of machinery to accept that the
eventual wear and decay of any mechanism is
inevitable. In keeping with this, the aging of the body
is compared to the wearing out of old machines and
assumed to represent a similar process. In fa ct, the
resemblance is only superficial. Aging in mammals is a
pre-programmed stage of development brought about
as purposefully as puberty and similarly determined
by evolutionary forces. Two basic pieces of evidence
support these ideas and run counter to aging
hypotheses which postulate an inevitable accumulation
of damage, genetic errors, or toxins: First, every species
has a characteristic lifespan. Within phylum Chordata
(the vertebrates) at least, lifespan is more precisely
regulated in higher forms such as mammals, than in
lower ones, such as fish.
Second , the
rectangularization of human survival curves with
improved social conditions and medical care indicates
that, although the average lifespan has increased over
the past few centuries, the maximum spans achieved
have not. In humans, death occurs no later than one
hundred years or so after birth. '
ABOUT THE AUTHOR:
Ross Mantle is a third year medical student at the University of Western
Ontario. He received a BSc degree from the lAurentian university. This article
is a condensed version of a Problem-based learning (PBL) honours project.
The joumal encourages students to submit condensed versions of such
projects for publication.
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BIOLOGICAL TIMING
Assuming aging is preprogrammed,
be a means within each individual of "<='"""..
time with reasonable precision and initia
the
appropriate developmental changes. Such a biological
"clock" would require, by analogy to mechanical
clocks, an oscillator with a fixed frequency (the
"pendulum"), a means of adding up the oscillations to
mark off larger blocks of time, and a way of
communicating or acting on this information (the
"hands").
Circadian rhythms are daily cycles entrained to the
rotation of the earth by certain cues, called zeitgebers
(time givers) such as light, temperature and the tides.
For most species, the most potent zeitgeber is light. In
the absence of external stimuli, true circadian rhythms
continue, but with a period that is usually slightly
faster or slower than 24 hours. An oscillating
mechanism consisting of a series of enzymatic protein
conversions forming a cyclic cascade, has been
proposed as a general model. Although little solid
experimental evidence exists to support this idea, the
pendulum of our internal clocks may have evolved
from the synthetic response of the organism ' s
enzymatic machinery to the daily pattern of stresses
imposed on it by the environment. The accuracy of the
period of a circadian rhythm running in the absence of
environmental cues2 can be better than ±0.01 h/ cycle in
single celled yeasts.
The means by which a biological clock might mark
off the passage of days, months and years is the least
understood component of biological timing. In order to
explain four day estrous cycles, menstrual cycles and
other timed occurences involving intervals which are
much longer than one day, the "resonance hypothesis"
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po tulates a beat phenomenon between two oscillators
operating at slightly different frequencies . Beats in the
levels of neurohormones mar trigger developmental
changes including senescence.

THE MAMMALIAN HYPOTHALAMICPINEAL AXIS
THE PI EAL
The pineal gland was named for its pine cone shape
and resides in the brain . Phylogenetically, the pineal
organ is known to have been a third, median eye in the
forehea d s of the dinosaurs and many primitive present
day ve rtebrates. The closest living relative of the
dinosaurs, the tuatara of New Zealand (Sphenodon
punctatum), is a large lizard which still exhibits a welldeveloped third eye in the middle of its forehead. The
third eye may have a lens and retina, although the eye
never approaches
the image-forming capability of the
4
lateral eyes. The pineal organ, or epiphysis, is found in
the brains of among the most primitive of vertebrates and
the most advanced (with the possible
exception of one
5
mammal, the nine-banded armadillo). Over the course of
evolution the pineal gland has been highly conserved.
Pineal eye information keeps organisms in synch with
their environment , communicating not only whether it is
night or day, but also the season, most likely based on
whether the days are lengthening or shortening. Such
information is necessary for migration, seasonal changes
in plumage or fur colour, food storage and hibernation
behaviours, and breeding.

THE SUPRA CHIASMA TIC

UCLEI (SC )

This portion of the brain is now considered the master
circadia n oscillator in birds and mammals. The SC is
an oscillator which can function independently, but
which is also e ntrained to the ambient photoperiod
through its connection with the optic chiasm. Once the
SC , entrained to external lighting, reaches the "night"
portion of its cycle, nerve impulses are sent to the
pineal, which responds with an increased activity in the
rate limiting synthetic enzyme for melatonin,
acetyltransferase. Melatonin is then secreted$
feeding
6
back to the SCN in a classic loop arrangement. .
MELATO IN AND PINEAL SECRETIONS
Mela~onin is synthesized almost exclusively in the
pineal. In primitive vertebra tes, melatonin causes
clustering of melanin pigment within melanocytes
leading to an overall depigmentation of the skin.
The first inkling of a broader range of function for the
pineal came when Otto Heubner observed that tumours
which destroyed the pineal in young children resulted
in precocious puberty. High levels of melatonin have
been found to suppre s gonadal development, such that
rats kept in continuous light (so that nighttime pineal
ecretion of melatonin is su ppressed) have increased
gonada l development, and nighttime melatonin levels
drop by 75% over the course of puberty.• Melatonin is
ecreted at night in both nocturnal and diurnal animals.
The pineal is associated with psychiatric disease in
humans, particularly affective, schizo-affective and
schizophrenic disorders . Evidence of disturbances in
circadia n rhythms in these patients has led to the
specula tion that the cau e of many of these problems is
desynchronization, improper phase relationships or
beat phenomena (especially in bipolar
affective
5
disorder) in internal timing mechanisms. Perhaps the
most drama tic example of the psychiatric effects of
pineal func ti on involves the successful
treatment of
10
seasonal affective disorder with light.

THE ANTI-AGING EFFECT OF MELATONIN
A group of scientists in Switzerland recently made a
discovery which may have very profound implications
for the future practice of medicine. In the course of a
three year experiment in which mice were given nightly
doses of melatonin starting at 1.6 years of age, the
melatonin group lived 20 % longer on average than
controls."
Only two other experimental manipulations are
known to sign ificantly increase lifespan in mammals:
subsis tence
level
caloric
r estriction
a nd
12
•
•
hypophysectomy. The former effect was ongmally
observed in 1935 by McCay and colleagues and has
since become a cornerstone of aging research with a
large13 number of new discoveries being made each
year. Food restriction can retard aging to the extent
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that lifespan is increased up to 30%. Hypophysectomy
has been shown to have similar, though smaller (-11 %)
We-prolonging effects with or without efforts to replace
pituitary hormones. HypophY,sectomy
may also be
14 15
combined with food restriction. • For a review of the
effects of food restriction and the manipulation of
endocrine glands on aging, see Everitt and Meites, 1989.
THE MELATONIN EXPERIMENT
A three year experiment was conducted in which ten
black male mice were given drinking water containing
0 .01 mg / ml melatonin. Both the ten mice in the
experimental group and ten controls were allowed
access to drinking water only at night, from 6 pm to
8:30 am. The mice were kept in cages with burrows in
which the mice could sleep during the day. A constant
12:12h light-dark cycle was maintained at a temperature
of 23 °C. The average lifespan was 2.06±0.22 years
(752±81 d) in the controls, and 2.62±0.22 years (931±80
d) in the melatonin group. This represents an increase
in lifespan of about 20%, significant to p<O.Ol.
At least two methodological criticisms of this work
can be raised . One involves the use of syngeneic mice
(strain C57BL / 6J). As is well known, highly inbred
s train s of lab mice may have precisely determined
lifespans due to the consistent development of a fatal
lesion s uch as a brain tumour at a certain age. The
administration of a drug which is effective against that
specific ailment may prolong life without retarding the
actual aging process . The Swiss experimenters,
howeve r, believe that melatonin acts on aging itself
chiefly becau e of the youthful appearance, activity
pattern and body weight of the mice on mel a tonin .
Another possible source of error in interpretation in the
melatonin experiment is the con tant 12:12 h light-dark
cycle . Mice are seasonal breeders with a four day
estrou cycle. Since all the subjects were male, estrous
cycling would not be expected to play a role. However,
the lack of seasonality may have had an effect on the
outcome of the experiment.
These results have since been replicated with other
syngeneic strains and using females. Starting mela tonin
at one yea r rather than 1.6 years actually shortened
survival in C3H / He female mice by inducing ova rian
cancer, although longevity enhancement was 16r tained
when the melatonin was started at a later age. Similar
tri al involving both males and females in natural
(seasonal) lighting would be interesting.
POSSIBLE MECHANISMS FOR THE ANTI-AGING
EFFECT OF MELA TO I
Arm trong and Redman theorize that melatonin acts
as a nightly synchronization signal which entrains all of
the daily rhy thms in the body o that they may act in
concert. A decrease in the amplitude of the melatonin
signal with age might therefore result in progressive
desynchronization of the body's rhythm and

20

consequent loss of 17function in all systems, leading
eventually to death. According to their interpretation
of the melatonin experiments, exogenous, nightly
melatonin strengthened the natural nightly level so that
internal synchronization could be maintained for a
longer time. This "progressive desynchronization "
theory of aging is not new, and was probably first18
elucidated by Aschoff in the nineteen sixties in the US.
Several current papers document the decrease in the
.
•
•
19· 21
.
mghtly melatonm pulse m humans.
Nightly
melatonin peaks decrease in a 22fashion that is roughly
exponential with increasing age.
EFFECTS OF PINEALECTOMY
Pinealectomy has been shown to produce a syndrome
similar to that seen in aging, including a rise in
cholesterol, triglycerides and circulating phospholipids
(Pierpaoli et al, 1991), hypertension, loss of electrolyte
balance, diabetes-like symptoms, dissociation of rapid
eye movement sleep from slow-wave sleep, elevation in
alkaline phosphatase, increased formation of abdominal
fibrous tissue (adhesions), increased skin pigmentation,
and reduced formation of prostaglandin E1 and
thromboxane A. Many of these symptoms can be
countered by administration of exogenous melatonin
at
17
the appropriate time (early subjective evening).
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DOMIZED CLINICAL TRIAL OF MELATONIN
HUMA S
23

The very low toxicity of melatonin and the fact that
it has bee n used to good effect in clinical trials on sleep,
. h th e
p ychiatric disorders an d jet lag 10,24 toget h er w1t
evidence concerning its effect on the longevity of mice
su gges t that the time may be appropriate for clinical
trials on humans. A medium scale randomized clinical
trial involving a modest dose of melatonin
at night only
17
( orne authors s ugge s t 2.5 m g/ d) and enlisting
subjects in la ter life, perhaps starting at age 65, would
provide invaluable opportunities to s tudy the effect of
the s ubstance on sleep patterns, d e pression, infection,
hy pertension, blood cholesterol, tumorigenesis and ,
over an extended period, longevity.
I would like to thank Drs. Flummerfelt and Walker for
their practical advice.
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AN

INTERVIEW

WITH

DR.

LeRICHE
by Susan Huh , M eds '97

INTRODUCTION
r. Nicole LeRiche began her 16-year association with
the UWO Faculty of Medicine in 1977 as an intern.
After obtaining her FRCPC in Internal M edicine, she
engaged in clinical studies in rheumatology at the National
Institute of Health (NIH) in Maryland from 1982-84. Since
her return to London in 1985, she has served on n umerous
committees, published severa l papers, and taught both
undergraduates and graduates. She and her husband, Dr.
John H owa rd , have also found the time to raise three
children. Dr. LeRiche was appointed as "Depu ty Dean " in
the Spring of 1993; this title has since been changed to
Associate Dean of Academic and External Affairs.

D

RHEUMATOLOGY
Why did you
rheumatology?

choose

to

subspecialize

in

"I like internal medicine, and I think rheumatology
really spans a lot of internal medicine as an intellectual
discipline ... There's a need for rheumatologists. There
are so many people who could benefit from seeing a
rheumatologist there's usually an oversupply of
patients.
Knowing that I wanted to be able to control my
hours to a greater extent than I would be able to if I
were doing general internal medicine was a prime
consideration, because at that time I knew that my
husband and I would want to have children and I knew
that my husband was also doing internal medicine. That
was one way we could negotiate that difficulty of
having enough time for ourselves, our family and so on.
It was a combination of things that helped me make the
decision."

BEING AN ASSOCIATE DEAN
How did you become an Associate Dean?
"You really have to ask Dr. McMurtry as to how I
came here- Dr. McMurtry is the one who asked me
whether I would do what I am doing. I think some of it
occurred as a result of the fact that I was invited to be
part of the Strategic Planning Exercise which went on
last year. Last year, because of the fact th a t Dr.
McMurtry had recently arrived on site, he wanted to a
have a good idea about a number of issues within the
faculty.
Early in January, when he was making selections for
Assistant and Associate Deans, he asked me if I would
be interested in the post of " Deputy Dean". My first
reaction was one of amazement, but the more I thought
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about it the more interesting it sounded. Certainly, it
was nothing I necessarily would ha ve applied for
myself.

Bioniche
A new emerging Biopharmaceutical
company requires a research nurse to be
part of its clinical research team.

Basic requirements:
•
•
•
•
•
•
•
•

Nurse (BSc preferred)
Experience in clinical trials
Experience in Urology/Oncology
Excellent commmunication skills
Dynamic, self motivated, organized
Required to travel within Canada
Bilingual (preferred)
Computer experience an asset

Send resume to:
Dr. Ingrid Van der Linden
Bioniche Inc.
27-69 Bessemer Rd.
London, Ontario N6E 2V6
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What is the role of an associate dean?
"My role as I see it is to do a number of different
thing . I have responsibility for so-called clinical affairs,
which is looking after the Faculty Practice Plan; this
plan involves how faculty are paid. In addition, I may
stand in for the Dean if he's absent. I'm on a number of
task forces which have been struck within the faculty as
a re ult of the Strategic Planning Exercise. I think by
being on a number of task forces, I have a fair idea of
what's happening in all of th em, so there will be a
minimum of duplication in other task forces .
I think what Dr. McMurtry had originally intended
was that the " Deputy Dean" act as a "backup" - to
stand in for him as needed. The official title of As ociate
Dean of Academic and External Affairs merely reflects
the breadth of things that he' d like me to be involved
with, and that I'd like to be involved with."
What kind of an impact will your position have on
faculty and students?
"The kind of impact that I'll have is more easily seen
with faculty. By extrapolation, if faculty feel better
about things in general then students will feel better
about things in general.
I think what we're trying to do is make changes
which will better reflect what people do, how they' re
rewarded, and how we carry on day-to-day operations
withi n the faculty. As an example, there's a
com munications task force ... trying to look at
communications in general across the faculty. I like to
think of that as not only the cut-and-dry memo-sending
that goes on, but in fact how we talk to one another. Is
there a sense of belonging, and cohesion, a sense of
esprit-de-corps within the faculty itself? ... I think that if
we can find ways of recognizing people in meaningful
ways so that they feel that they' re part of the faculty,
that feeling will grow ...
Bear in mind the difficulty at times in how to get
va riou parts of the faculty talking to one another on
everal levels: "talking" in the ense of doing research
with one another, how to teach most effectively, how to
do the best patient care you can, that kind of thing ... I
see my role perhaps as a facilitator of those processes; I
have no illusion that one person can do it, but if there
are a number of people whose aim it is to improve a
number of those things, it's more likely to happen."

Littmann™
Master
Cardiology
stethoscope

coustical excellence,
ovative design,
tched performance

Do you still find time to practice?
"I had a very full clinical practice before I started this
position, and still do . [laughter] It's a little bit of a
challenge to try to fit everything in. I still feel a great
responsibility to continue to see patients, but I have had
to cut back a little bit, because of the fact that I'm doing
a lot more with the Faculty. It's funny, I was reflecting
on that a few weeks ago ... I think it gives me a
perspective that is really critical, that I'm still doing the
U. W .O. Medical Journal 63 ( 1 ) 1 9 9 3 - - - - - - - - - - - - - - - - - - - - - - - -

23

Articles
day-to-day stuff that many of my colleagues a re also
doing ... I think it's very important not to become
divorced from what our primary goals are, which I see
as teaching medical s tudents, doing research , and
seeing patients. All those things are very important."

STRENGTHS OF UWO MEDICAL SCHOOL
" I think one of the thing s that I found really
refreshing when I came here, was the fact that people
seemed to be very approachable. I think and I hope that
s tudents feel that. At times I worry th at th e re are
perhaps unnecessa ry barriers that exist, studen ts
presume things about consultants and vice versa. But I
think on the whole there ' a reasonably c ordial
atmosphere here.
I think that the quality of teaching is good. I'm
concerned, and thi s is being addressed in the
curriculum, about overstuffing people with facts. But I
think that certainly the kinds of trainees with whom I
work are excellent. They ' re well-trained, they're
knowledgeable, they're kind people, they're the kind of
doctors that I would want to go to. I think on the whole,
that whether it's the admissions policy or just the
institutional ethos in general the people are delightful."

PROBLEM-BASED LEARNING

Dedicated
to Respiratory
Care
ri\ Boehringer
~ lngelheim

Boehringer lngelheim (Canada) Ltd.Jltee
5180 South Service Rd., Burlington, Ontario L7L 5H4

Why is the school moing toward a more completely
problem-based learning curriculum, considering the
success rate of Western's graduates?
"I think there is a recognition on the part of not only
physicians practicing within the system, but the public
as well , that phys icians who have very good
communica tion skills, and who are empathic would be
preferred . I think this is more easily taught within the
context of a small group, and examining a variety of
different problems from a number of different angles."

-·
.......
..
:·..
.•...

WOMEN IN ACADEMIC MEDICINE
"Young women may be starting to select themselves out
of doing sc ience and things like that w hi ch are
prerequisites for medicine ultimately, because there's
sort of a societal view that this isn't really women's
work. I think that's happening less and less.
There ma y not now be the active discrimination
which existed before, but unfortunately there may well
be barriers ...
There are some things within the system which do
make it harder for women to either become part of the
system, or to su cceed in the system. I think that we're
trying to make changes that will make tha t ... easier.
Certainly Dr. McMurtry is, I think, very aware of that
difficulty."

Seeking Year by Year,
Day by Day...

Breakthroughs in
Medicine
and Knowledge

Westrlveto..-lhe-

Why hasn't the increase in female enrollment in
medical school been accompanied by an equivalent
increase in all specialties of medicine?
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"A lot of reasons. A lot of it is selfselection . .. women want flexibility , and
certainly my friends doing family p ractice
probably have greater flexibi lity. If they want
to have children, they can take that time off to
be home with thei r child much more easily.
The more one s ub s pecializes, the more
difficult that b eco me s becau se it's more
difficult to replace yo u in a particular
situation."

THE STATE OF CANADIAN
HEALTH CARE
" I think tha t many people didn't realize that
there ha s beens a nd is a finite quantity of
resources. Unfortunate ly w ha t happe ned i
that people were pending as if there weres
no tomorrow ...
Things eem a lot bleake r when one ha
been raised in an environment of incredible
plenty which then become re tricted. I think
that this is the i s u e w hi c h we are a ll
grappling with. The feelings of frustration are
und ers tandable because we have come to
enjoy a very good sta nd a rd of living on the
w hole ...
If we as a profession recognize wha t our
goa ls are, and w h e r e we want to s p end
money and how we wan t to spend ou r time,
we can still do what we want to do ... we must
all be accountable for our pending ... ' we' re
all part of the ystem, and we all have
responsibilities to try and make the best u es
of the resources that we have' ...
I'm concerned by the fact that things have
become so provincial, because I see myself a
a Canadian, I don't see myself as only an
Ontarian ... Everything else is becoming more
global- why are we becoming more
perochial? But it' an understandable reaction
because everybody feels threatened ."

PERSONAL GOALS
"I like to think of life as a series of adventures
and that variou things occur and you're
lucky enough to meet interesting people ... I
suppose that a major goal is in trying to be
the best physician that I can be, to learn as
mu ch as I can, and as well to try to convey
tha t desire to other people ... perhaps we have
to be more in touch wi th and allow our elves
time to think about tho e important things
which make up life. In a peculia r way, we as
physicians are o intensely involved in other
people's li ves that we forget the big picture
and don' t think about how amazing life is."

n
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NEUROLOGIC SEQUELAE OF
HUMAN IMMUNODEFICIENCY
VIRUS-1 (HIV-1) INFECTION
by Jeffrey M. Politsky, MSc, Meds '94,
David M Pelz, MD, FRCP(C), Meds '75, & Thomas W. Austin, MD, FRCP(C), Meds '65

ABSTRACT

INTRODUCTION

uman Immunodeficiency virus-1 infection is a
commonly occurring and an incompletely understood
illness which can have severe effects on the central
nervous system. Theories of disease transmission relate to
immune-mediated transfer, endothelial cell infection, and cellspec ific susceptibility . Neuropathologic alterations include diffuse
and focal brain changes, and may
occur secondan; to enhanced cellular
immunity, increased secretion of viral
proteins, and /o r excitotoxic
mechanisms of cell damage. Central
neurologic findings include the AIDS
dementia complex and acute and
subac ute focal brain disea ses.
Recog nition of the neurologic signs
and
symptoms
of
human
immunodeficiency-1 virus infection
clinically and through the use of
neuroimaging techniques is critical
for effective therapy. Despite
therapeutic intervention, prognosis of
human immunodeficiency virus
infected patients remains guarded.

Systemic human immunodeficiency virus-1 (HIV-1)
infection is a common ye t incompletely under tood
illness. This illness, specifically the late phase of
acqui red immunodeficiency syndrome (AI DS ), is
complicated by direct central nervous system (C S)
infection and by neurologic disease
from the onset of the initial illness.
eurologic sequelae of HIV-1
infection relate to the acquisition of
opportunistic infections and the
development of C S neoplasms.
Early recognition of the neurologic
signs
and
symptoms
has
implications for both diagnosis and
management of HIV infection and
AIDS. Further, diagnosis and
management can provide clue to
the underlying mechanisms of HIV1 infection. This paper provides an
overview of the neurologic
complications of HIV infection,
including theories of transmission
and neuro-pathology. As well, the
clinical neurologic findings of HIV infection are outlined
- recognition of these signs and symptoms has
diagnositic and therapeutic significance.
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TRANSMISSION
The exact mechanism of transmission of HIV -1 and
HIV-1-related secondary infections into the C S is
currently unknown. Possible mechanisms of transmission
are based on findings that hematogenic and/or neuroglial
cells may be preferential tar&~ts for HIV -1 and HIV -1related secondary infections. One theory is immunemediated transfer of vira l particles .' For example,
although microglial cel ls are the primary target of
retroviral infection, these cells lack CD4 receptor sites (the
HIV-1 cell surface receptor protein). These cell do,
however, have high affinity receptors for
imrnunogloblulin, making antibody-mediated uptake into
brain tissue a possible mechanism of infection.' Other
studies also implicate neuroglial and hematogenous cells
as bein&} nvolved in the transmissability of virus
particles. This involvement is based on the observation
of budding of HIV-1 particles from cell membranes of
multinucleated giant cells (macrophages) and monocytes
predominantly, although neuroglial cells are also
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involved.u These findings suggest ingestion, djgestion,
and replication of HIV-1 by brain macrophages.
Another theory suggests endothelial cell infection as
the primary mechanism.• For example, immunohistochemical localization of CD4 and HIV-1 antigens to
cerebral and lymphatic venular endothelial cells
supposes either natural occurrence or induction of CD4
protein in various endothelial cells, thus allowing HIV-1
to be transmitted4 from circulating infected leukocytes to
targeted tissues. This study also suggests that the high
HIV-1 immunoreactivity of macrophages and
multinucleated cells in post-mortem tissue may be due
to immune-mediated sequestration of HIV-1 antigens
from initially infected hematogenous cells.'
Neuroglial cells also appear to be sensitive to HIV-1related secondary infections. For e.g., one 37 year old
HIV-1-positive man with a history of pneumocys tiscannu
pneumonia
died
of
disseminated
cytomegalovirus
(CMV)
infection
and
an anaplastic
5
astrocytoma. CMV-bearing astrocytic cells were found
throughout the tumour, but not elsewhere. As well,
CMV-bearing endothelial cells were noted in several
capillaries within the tumour. Microglial nodules and
multinucleated giant cells (MGCs) were also found in
the tumour and also stained posi tive for CMV. These
authors concluded that astrocytoma cells are permissive
to CMV, that these cells are more susceptible to CMV
infection and replication than normal tissue, and that the
entry of CMV may be due to alterations in the
astrocytoma blood brain _barrier (BBB) and the
hyperplastic endothelial cells., These factors may play a
role in the development of opportunistic infection in the
presence of other C S neoplasms.

NEUROPATHOLOGY
europatholgic studies carried out on post-mortem
brain tissue from HIV-1-positive induviduals are critical
in furthering our unders tanding of the neuro logic
sequelae of HIV -1 infection and AIDS. These studies
have revealed that specific areas of the brain are
preferentially affected in HIV-1 infection. As well, HIV-1
and HIV-1-related secondary infections have a
predilection for certain neuronal cell types. The
development of HIV-1-related secondary infections
represents an important aspect of neurologic disease in
AIDS. Clinically, these opportunistic infections may lead
to the development of AIDS dementia complex (ADC).
Pathologically, these infections signal the terminal stage
of AIDS. Although some explanations are forthcoming,
the mechanisms underlying these various pathologic
changes remain unclear.
europathologic alterations occurring in 6,AIDS
are
10-12
associated
with
the
cerebral
hemispheres,
basal
9
24
ganglia·"" brain stem structures and spinal cord, inferior
.
o 11vary
nuc 1e1,. 13 corticospina 1 tracts, 6 an d t h e eye. 14.32·36
Primary histopathologic findings in brain tissue fro m
AIDS patients can be divided into diffuse and foca l
changes. Diffuse changes include cortical atrophy, w hite
matter pallor, vascular calcification, multinucleated cell

28

5 8 9 14 16 18 22

encephalopathies, and vacuolar myelopathy. ' ' ' • ' •
Focal changes include the acquisition of various
opportunistic infections, encephalitides, malignant
neoplasms,
and
pro~nessive
multifocal
'81. 13,15- 17. 19-22
1e uk oencep hal opa th y (PMLE) .
DIFFUSE CHANGES
Cortical atrophy is the most consistent finding in the
cerebral ~~flli~here~ of AIDS patients with neurologic
sequelae.
Cortical changes are characterized by
significant
neuronal
loss in the frontal cortex" and otherII
. 10,23
f oc1,
a 1ong with decreases in neuronal density,
25
perkiaryon volume fractions, " and widened sulci. A less
common finding is cerebral spongioform changes of the
white matter,
characterized by small rounded
23 25 3 1
vacuoles . ' ' A more diffuse sponginess, status
s pongiosis, charac terized by looser and coarser
microcvstic
cavitations has been observed in the gray
tl,25.31
matter.
Subcortical structures are commonly involved in
AIDS patients with neurologic complications. The most
common histologic finding is diffuse white matter pallor
with astrocytic reaction. Also common is dystrophic
9
calcification of blood vessels in the basal ganglia."" The
observation of MGCs is an indicator of more severe
neurologic disease. Changes in these brains are found
mostly in the deep gray structures and white matter and
include gliosis, perivascular and parenchymal foamy
macrophages, formation
of microglial nodules, MGCs,
9 15 18
28
and lymphocytes. • • .25- Multinucleated cell encephalitis
is also called HIV encephalitis because of the correlation
between the presence of MGCs and opportunistic
infections. (see figure 1)
The most common pathologic finding in the s pinal
cord of HIV-1 infected patients with 12clinical
neurologic
13 25 29
symptoms is vacuolar myelopathy. • • • .JO Clinicall y,
vacuolar myelopathy is similar to subacute combined
degeneration secondary to vitamin B12 deficienc y;
pathologically, the two entities are 30distinct since in the
former, serum 8 12 levels are normal.

Figure 1
Axial proton density and T2 weighted images in a 40 year old male with
AIDS. Diffuse deep white matter high signal in both cerebral hemispheres
(a"ows) was pathologically proven to represent HlV encephalitis.
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Ophthalmic changes include ocular motor nerve
pal s ies, papilledema, CMV optic n euritis, cortical
blindness, conjugate gaze palsies, and altitudinal visual
field defects.' Retinal microvascular abnormalities in
HIV-1 infected patients can also occur-in fact, ocular
microan:@ iopathic syndrom e is common in these
patients. - The major retinal microvascular alterations
33
a re cotton-wool spots; other changes include retinal
h e morhages, ectasia of conjunctival
vessels, and
34 36
conjunctival blood-flow sludging. • The e retinal
change can be remarkably similar to those
in diabetes
32
mellitus and systemic lupus erythematosis.
FOCAL CHANGES
Major focal pathologic changes in the brains of AIDS
patients include opportunistic infections and neoplasms.
The most important pathologic processes are cerebral
to xoplasmosis,
PMLE,
and
primary
C S
9,15, 16, JS.:20.22.25
1ymp h oma .
Figu re 2
Axia l T 2 weight ed M R
image of the brain in a 33
y ear old fema le w ith
A ID S . Th ere is a large
irregu lar high sig nal mass
les ion in the deep right
temporal lobe and there is
a s maller nodu lar hig h
s ig nal m ass in t he left
f ro nt al lobe. Th ese both
represen t ma nifes tations
of cerebral toxoplasmosis.

Cerebral toxoplasma (se e figure 2) lesions are
multifocal and ~ve a predilection for the ba a! ganglia
a nd the cortex . Papovaviru s, or PMLE, tends to be
localized to the white matter and is associated with an19
a bse nce of inflammatory infiltrates (see figure 3).
Primary C S lymphoma ma y a lso have multiple
foci
25
and i usually identified in the white matter. (see Fig 4)

Figure 3
Axial proton density and T2 weighted MR images in a 62 year old female.
Irregular high sig nal changes are seen in the periventricular white matter
adjacen t to tl1e atrium of the (arrows) left lateral ventricle and also in the
pos terior limb of the right internal capsule. These were pathologically proven
to represent PMLE .
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Currently, there is no decisive explanation for the
neuropathologic changes in AIDS. One theory suggests a
hypersensitivity reaction.• The interaction between the
CD4 antigen (Ag) and Ag-presenting cells lead to
enhanced cellular immune activity. The interaction of
immune related Ag's on CNS vascular endothelial cells
lead s to a breach of the BBB a nd could lead to the
a cqui ition of opportunistic infections and HIV
vasculitis. • Another possibility is that AIDS-associated
neurologic disease is correlated with higher levels of
HIV -1 Ag in tissues, which ultimately leads to increase
secre tion of viral proteins or viral induction of
cytokines. These substances then bind to glial cells and
neurons stimulating a positive feedback loop (with28
further secretion of viral proteins and/or cytokines) .
Finally, an excitotoxic mechanism of damage has been
37
proposed . .38 In this theory, the final common pathway
of damage may involve voltage-dependent calcium
cha nnels and NMDA receptor-operated channels, in
mu c h the same wa;r_ a s damage occurs in stroke,
seizure , and trauma . .38

CLINICAL PRESENTATION
The clinical pre entation of HIV-1 infection has39been
subdivided into four distinct phases (see table 1). The
development of neurologic signs and symptoms in AIDS
i u ually associated with phase IV illness, but distinct
symptomatology such as ocular and psychiatric findings
ma y occur at earlier stages . Nonetheless, the
presentation of neurologic sequelae is an indication of
advanced disease.
Clinically, neurologic findings of AIDS fall under
va rious catego rie . Some of theses categorie include
ocular, psychogenic, myelopathic, and central findings .
Th e bulk of this discussion concerns the central
neurologic finding , which can be subdivided further
into diffuse (AIDS dementia complex) and focal brain
disease.

Fig ure 4
Axial proton density M R image in a 41 year old male with A IDS. Irregular
pe riventricular hig h sig na l les ions (arrows ) are seen bilatera lly w hich
represent primary CNS lymphoma .
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TABLE 1

CLINICAL STAGING OF HIV-1 INFECTION
Stage
II
ill
IV

a)
b)

c)
d)
e)

Acute HIV Infection
As
toma tic Carriers
Persistent Generalized L
Constitutional Disease
Neurological Disease
i} HIV-related
ii) Opportunistic Infections & Neoplasms
Secondary Infectious Disease
Secondary eoplasms
Other Conditions

OCULAR FINDINGS
Ocular changes and ophthalmoscopically visible
changes have been observed in
AIDS patients with
24
clinical stage III and IV disease. .34.36 The most common
occular finding
appears to be limitation of central eye
24
movement. Less common, but occuring equally
frequently are peripheral eye movement limitations,
abnormaliti~r of vision, and abnormal spontaneous eye
movements.
PSYCHOGENIC FINDINGS

Although a certain percentage of diffuse brain
di sease relates to metabolic encephalopathies
occurring secondary to systemic disea se such as
pneumonias with hypoxia and generalized sepsis,
the commonest CNS complication of HIV infection
is a constellation of neurologic sig n s and
sy mptoms referred
to as the AIDS Dem entia
25
Complex (ADC).
AIDS dementia complex usually manifest itself
after patients acquire AIDS-defining sys temic
illnesses such as opportunistic infection s or
neoplasms (see table 2). The complex can occur,
however, in the absence of these major systemic illne ses
and is thus a separate entity among diagnostic criteria of
AIDS.o. .
Early symptoms relate to cognitive deficits, such as
difficulty concentrating, impaired
memory, and inability
19.25.26.42
t. o p er f o rm comp 1ex ta s k s .
In ea rlier stages of
Illn ess, formal mental status testing ma y be quite
normal. With increasing severi ty, howev e r, results
become abnormal and include apathy, poor insight,
impaire d 1925recognition
, recall , atte nti on
and
calculation. .26•42
'
Gross and fine motor dysfunction become evident
with the appearance of gait disturbances, poor balance,

TABLE 2

DIFFUSE BRAIN DISEASE COMPLICATING
25
HIV INFECTION
Level of Consciousness

Depre sed

Preserved

MYELOPATHIC FINDINGS
Transverse myelopathies are rare, but can occur
seco ndary to25spinal lymphoma and infection with
herpes zoster. Polyradiculopathy secondary to CMV or
combined CMV and herges simplex virus infections also
occur and can be severe. The most common spinal cord
finding is progressive vacuolar myelopathy . These
patients present with gait disturbance, ataxia, and
spasticity. Bladder and bowel dysfunction also occur as
25
myelopathy progresses.

30

CENTRAL NEUROLOGIC FINDINGS
Diffuse Brain Disease
(AIDS Dementia Complex)

Clinical Findings

Psychologic disturbances appear to
be re lated in part to the patient's
awareness of being HIV-1-positive.
These changes include depression 1
anxiety, and adjustment reactions .'o.•
The asymptomatic s tage of HIV
infection is not associated with41
sig nificant cognitive impairment.
Cognitive disturbances, which are
associated with clinical neurologic
symptoms and which may be revealed
by neuropsychologic testing include
difficulty with complex seq uencin g,
impaired fine and rapid motor
movement,
and s lowed verbal
19.25,42
fl uency.

39

Complicating Disease
Metabolic Encephalopathies
Toxoplasmosis ("encephalitic" form)
Cytomegalovirus Encephalitis
Herpes Simplex Encephalitis
Acute HIV-1 Encephalitis
AIDS Dementia Complex

and eye and hand incoordination resulting in patients
trippin g, falling down, dropping items
~ and finding
19 5 2
2 45
themselv es unable to eat or wri te. • ' ... ' Motor
dy sfunction can sometimes be detected early on by
recognition of abnormal or pathologic reflexes such as
glabellar, snout, and grasp re s ponses, as well as
generalized hyperreflexia. Also, disruption and slowing
of rapid sequential and alternating tasks involving
fingers, wrists, and feet occur. Other early signs include
ocular d ysmotility, disruptig n of smooth pursuit, and
slowed saccadic movements.
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End stage presentations of ADC include bowel and
bladder incontinence, a complete or nearly complete
25
vegetative tate, and marked reduction of arousal.
One author has suggested that
the "ADC" is really
6
seronegative neurosyphilis : This notion was
formulated on the basis of five AIDS patients who were
all diagno ed with ADC. Despite being seronegative for
n eu rosyphilis, the patients all showed a dramatic
im provement in function and a marked reduction in
impairment following either intravenous (iv) infusion of
penicillin G or oral administration
of doxycycline (the
46
treatments for neurosyphilis). Although neurosyphilis
can' t be ruled out despite seronegativity, this reasoning
i questionable on a few counts. First, only two of the
five patients underwent investigations beyond simple
serum and cerebrospinal fluid (CSF) studies. Further,
these two patients received computed tomographic (CT)
cans but neither magnetic resonance imaging (MRI) or
brain biopsies. The latter two procedures are currently
the most sensi tive diagnostic tools for the neurologic
complications of HIV-1 infection. Thus, diagnostic
attempts in these patients were incomplete. Second, the
positive response to penicillin may have occurred
because of another undiagnosed infection also sensitive
to this therapy. Third, although the possibiltiy exists that
the severe immunosuppression in HIV infection may
render serologic tes ts for syphilis unreliable, substantial
evidence is ava ilable to suggest that selologic tests for
syphilis are indeed sufficiently reactive:

Section

Most focal disorders are subac ute in nature and
evolve over days to weeks. Cereb ral toxoplasmosis,
primary C S lymphoma, and PMLE (papovavirus) are
three of the most important focal disorders . These
di order evolve rapidly over days, inter~ediat~X (days
to weeks), and slowly over weeks, respectively. These
di orders can produce overlapping, but often distinct
neurologic symptoms. For example, cerebral
toxoplasmosis usually produces a focal deficit along
with a generalized encephalopathy
leading to confusion
49
or clouded consciousness. .so PMLE, on the other hand,
produces focal deficits without any effeft
on
5
consciousness until end stages of infection . CNS
lymphoma can produce " frontal" or global mental
dysfunction when the lymphoma is associated with a
ignificant mass effect 51or is located deep in the frontal or
periventricular region.

DIAGNOSIS

A number of investigative procedures exist which,
when used in combination with clinical findings, may
lead to correct diagnosis of C S complications of AIDS.
Among these investigations, serum and CSF studies are
the most specific, ~ whereas neuroim
~g and brain
biopsy studies are the most sensitive.
Venipuncture
and lumbar puncture, to obtain se rum and CSF,
respectively, are inexpensive and useful techniques to
identify the presence of viral or bacterial-specific
proteins, immune complexes, and altered cell counts. ~
Focal Brain Disease
For patients with neurologic symptoms who either
require further localization of disease or whose CSF and
Apart from the diffuse brain processes discussed, a
serum results were non-specific, neuroimaging
variety of focal brain disorders develop in AIDS
techniques and brain biopsy are often necessary. There
patients. These focal disease processes may be acute or
appears to be some discrepancy as to which procedure is
subac ute in onset (see table 3), thus making clinical
the most sensitive among CT scan, MRI, and brain
recognition important for appropriate therapeutic
biopsy. For e.g ., in 149 patients examined with
intervention . Acute proces ses are usually due to
toxoplasma abcesses, CNS lymphoma, and PMLE, MRI
vascular events or seizures. Some vascular events such
was found to be more se nsitive
than CT scan in
58
as trans ient ischemic a ttacks or s trokes may lead to
detecting
lesions,
especially
PMLE.
CT
scan was unable
48
permanent brain injury, but most have a benign course.
to distinguish mass lesions due to toxoplasmosis
from
58
those due to lymphoma . Other studies
have also found MRI to more consistently
reflect the histopathologically documented
TABLE3
8
1
extent
and distribution of CNS disease. .su
Focal Brain Disease Complicating
25
Brain biopsy has also been used to achieve
HIV Infection
definitive diagnosis. For example, in one
study s tereotactic brain b io p sy was
Onset
Complicating Disease
performed after gadolinium-enhanced
MRI
63
Acute
Vascular Disorders
or contrast-enhanced CT sca n. After the
biopsy material was examined cytologically,
Subacute
Cerebral Toxoplasmosis
histologically, immunohistochemically, and
Primary CNS Lymphoma
by polymerase chain reaction, a definitive
Progressive Multifocal Leukoencephalopathy
diagnosi
s was achieved in 92 % of the
Tuberculous Brain Abcess (M. tuberculosis)
63
cases. In another study, definitive
Cryptococcoma
64
diagnosis w as reached in 96 % of cases.
Varicella-Zoster Virus Encephalitis
Brain biops y is considered to be a safe
Herpes Simplex Encephalitis
effective
means of diagnosis in this patient
Subacute CNS Syndromes
population.6U6
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PROGNOSIS AND TREATMENT

DISCUSSION

The effectiveness of treatment, and thus the
prognosis, of AIDS patients with neurologic sequelae
clearly depend on early and correct diagnos is and
intervention. Even with these measures, the prognosis
of HIV-1 infected and AIDS patients is bleak. The extent
of neurologic involvement is also a key factor in patient
outcome. For example, Mundinger et al. studied the
survival of 41 AIDS patients with neurologic
7
involvement based on neuroimaging re ults." The mean
survival of patients with initially normal imaging
results was 700 ± 89 days compared with 326 ± 65 days
and 202 ± 97 days for patients with cerebral atrophy
and focal lesions, respectively. The mean survival for
patients with both cerebral
atrophy and focal lesions
67
was only 78 ± 44 days. Further, these authors fo und
that, compared with initially normal imaging, the risk
of death increased 3.6 times with cerebral atroph , 6.4
times with focal lesions, and 19.3 times with both.
Medical therapy for neurologic complication of AIDS
usually involves antimicrobial agent for opportunistic
infections. To be effective, the e agents must cro s the
BBB and the blood-CSF barrier. Currently, there are
only a few such agents in use. Zidovudine is an antiretroviral thymidine analogue which has been shown to
be effective in reversing ADC to a lesser stage in most
seroP,ositive HIV pati e nt s with mild end-stage
A DC. !9.25.68
In light of the possible overlap between ADC and
neurosyphilis, a therapeutic trial of iv penicillin or oral
doxycycline may be warranted for patients who ei ther
don't respond to zidovudine, or who may in fact have
neurosyphilis.""
Cerebral toxopla s mo is is the most commonly
occurring opportunistic infection to ca u e encephali
tis
25 69 70
or multifocal brain lesion in AIDS patients. • •
Although this parasi tic infection is associated with high
morbidity and mortality, a good response to therapy
and an 25imroProvement in patient s urvival ha s been
shown. "'•· A therapeutic tri a l should be initiated in
patients who show neurologic signs and symptoms and
have th e characteristic lesions as evidenced by
neuroimaging or biopsy techniques. The most effective
anti-toxoplasma treatment currently available is the
combination of pyrimethamine and ulfadiazine, which
ca uses seq uential
blockade of folic acid metabolism in
70
25
the para ite. "'"· Therapy lasts for approximately three71
weeks, and may require the addition of folinic acid.69Pyrimethamine-clindamycin combinations have shown
so me efficacy in treating cerebral toxoplasmosis
and
69-71
may be used in patients with a ulfa allergy.
Like toxoplasmosis, C S lym phoma also produces
neurologic symptoms secondary to rna lesions. nlike
toxoplasmosis, however, few effective treatmen ts are
available for CNS lymphoma- teroid may be able to
reduce signs and symptoms eco58ndary to increased
intracranial pressure, but little else.

Over the last ten years, HIV -1 infection has been
shown to be a devastating illness with far-reaching
effects on mankind . HIV-1 infection affects a number of
organ systems, including the brain. This paper has
provided an overview of the neurologic complications
of AIDS. These complications are difficu lt to treat and
to control. Progress is continually being made in
understanding and managing these sequelae, but much
work still remains . As a result of previous research,
various theories explaining the causation of AIDS have
been postulated . Of these theories, the possibility that
neuronal damage in AIDS is mediated through
excitatory amino acid activation and increased
inracellular calcium appears promising. The
combination of MDA receptor activation, enhanced
inositol phospholipid metabolism, and toxic calcium
influx leading to neuronal cell death may be involved in
the pathogenesis of a variety of neurodegenerative
diseas es such as dementia of Alzheimer's t ype,
olivopontocerebellar atrop~ cerebrovascular accident,
and Huntington's disease;
recently, this mechanism
of cell 8damage has been extended to include th e
ADC.37.3 Developing mechanisms to arrest excitotoxic
cell damage are complex since they would involve both
extracellular and intracellular proce ses. Expanding on
this notion may lead to new therapeutic strategies for
the tre a tment of the neruologic sequelae of HIV -1
infection and AIDS.
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ABSCESS
by Glen Hooker, Meds '94

INTRODUCTION
renal infection, or pneumonitis. In
infants, bacterial seeding through the
hepatic artery may occur secondary
to umbilical vein catheterization.6
The presentation of bacteria to
the liver is insufficient to cause
pyogenic hepatic abscess; susceptible
liver parenchyma is required as well.
Examples of vulnerable liver states
include obstructive biliary disease,
biliary infections, and liver trauma.
In obstructive biliary disease (e.g .
cholelithiasis, obstructive malignancy
of common bile duct or pancreas; see
EPIDEMIOLGY
Fig. 1), or biliary infections (empyema
of the gallbladder, cholangitis),
In the United States, Figu re 1: The liver is riddled with multiple abscesses, bacteria multiply in the bile ducts,
pyogenic abscesses account secondJJry to a stone in the common bile duct.
and ascend into the liver via the bile
for 80% of all liver abscesses;
ducts. In addition, portal and
lymphatic invasion by these bacteria produce pus, which
pyogenic abscesses occur in 8-15 people per 100,000
enters the liver directly . Trauma is associated with
population. 1 The incidence is higher in countries where
increased risk of developing a liver abscess via bile
medical care is not readily available.2 Despite recent
leakage, decreased perfusion, hepatic necrosis, direct
advances in diagnosis and therapy, the incidence of
introduction of bacteria , and hematoma formation.
pyogenic liver abscess has remained stable, probably
About one-quarter of all liver abscesses are cryptogenic
due to increased survival of patients who have intrain origin, with no underlying source identified, even
abdominal diseases. 2 Males are affected more than
after visual and manual exploration of the abdomen?
females (3:2 ratio).3 The peaks of occurrence are during
In adults, conditions associated with the formation of
the first year of life and between 60 and 80 years of
age. 4 There appears to be no racial susceptibility.S
pyogenic hepatic abscesses include malignancy being
treated with chemotherapy, colon cancer, diabetes
PATHOPHYSIOLOGY
mellitus, and cardiopulmonary disease. In children,
associated conditions include malignancy, AIDS,
polycystic disease, cholecystitis, necrotizing
In order for a pyogenic liver abscess to develop, at
enterocolitis, and non-AIDS immunodeficiency states
least two pathologic processes must occur. The liver
(e.g. chronic granulomatous disease).B
must be both exposed to bacteria and vulnerable in
some way to the bacteria.
Normally, an efficient clearing mechanism, involving
scavenging reticuloendothelial Kupffer cells, prevents
Bacteria may reach the liver via the portal vein, the
hepatic artery, the biliary tree, or by direct spread.
colonization of liver parenchyma by bacteria. But when
Portal venous spread starts as thrombosis of mesenteric
the presence of bacteria in the liver is complicated by
veins at the site of an inflammatory process, commonly
the presence of necrotic tissue, hepatic injury, malignant
an intra-abdominal infection such as appendicitis or
tumours, microemboli, poor perfusion, or biliary or
vascular obstruction2, the bacteria are able to multiply,
diverticulitis. Septic emboli, which reach the liver via
invade liver parenchyma, and form an abscess.
the portal vein, are subsequently formed creating foci of
intense inflammation in the liver. These foci coalesce to
PATHOLOGY
form an abscess. Bacteria may reach the liver via the
hepatic artery, as in the case of generalized sepsis
secondary to conditions such as bacterial endocarditis,
Grossly, hepatic absce ses are more likely to appear
on the right side of the liver than the left by a 3:1 ratio.9
ABOUT THE AUIHOR:
Perhaps this difference is due to streaming of the
Glen Hooker is a 4th year medical student at the University of
superior mesenteric vein fraction of portal flow into the
Western Onatrio. He is expected to receive his MD in 1994. Mr
right lobe of the liver. lO Multiple abscesses occur as
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often as solitary abscesses.2 (see table 1) A solitary
n hepatic abscess is a
localized collection of
pus in the liver. Such
an abscess may be bacterial
(pyoge nic) , parasitic, or
fungal. The present discu ssion will be limited to the
pyogenic type. Further, this
paper will focus on the
cha nges in epidemiology and
etiology, and the recent
advances in diagnosis and
treatment.
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abscess may vary in size from a few millimetres to
several centimetres. The liver itself may be enlarged
and adherent to surrounding organs due to capsular
inflammation2. Microscopically, the liver will display
an acute inflammatory reaction with necros is and
hepatocyte cords in the portal triad regions.2

M ICROBIOLOGY
Ln more than half of patients with liver abscess, the
abscesses contain more than one organism when the
abscess contents are cultured. Specific organisms
recovered vary greatly.
Organisms found generally reflect biliary or enteric
flora . The most common aerobic organisms are E. coli,
Klebsiella, and enterococci (e.g. Streptococcus faecalis).
The most common anaerobes are Bacteroides, anaerobic
streptococci (e.g. Peptostreptococcus), and Fusobacterium
spp. Isolated colonies of E. coli or Klebsiella are
suspicious for a biliary source, whereas anaerobepositive cultures are suggestive of a colonic source2.
Staphylococci, hemolytic streptococci, or other g rampositive organisms are found if the primary infection is
bacterial endocarditis or pneumonitis. Recent studies 11
using improved culture techniques have found nonhemolytic streptococci and normal oral flora to play a
more prominent role.
There appears to be an increase in the number of
cultures posi tive for anaerobic and microaerophilic
organisms. Possibly, this increase is secondary to
improved culture techniques. Cultures positiv e for
anaerobes are usually positive for other organisms as
well; thus, broad-spectrum therapy is usually required
if anaerobes are present.12

D IAG N OSIS
Hepatic a b scess is associated with a number of
symptoms and signs. Symptoms include fever (often
erratic, and spiking to 40-41 "C), chills, rigors, right
upper quadrant pain, malaise, fatigue, weight loss,
night sweats, nausea, and vomiting. Physical findings
include right upper quadrant tenderness, pl e ural
dullness to percussion, hepatomegaly, and jaundice.?
A number of cellular changes occur which may aid
diagnosis of pyogenic hepatic abscess. For example, a
leukocytosis of greater than 15x109 / L (often with left
shift) and anemia of chronic disease are present in most
patients . Most patients have an elevated alkaline
phosphatase and an elevated gamma-glutamyl
transpeptidase (_-GTP) since a liver abscess is a spaceoccupying lesion.12 In some patients an increase in
aspartate aminotransferase (AST) and al a nine
aminotransferase (ALT) may be observed . An elevated
total bilirubin may be seen in cholestasis secondary to
hepatic structural collapse. Blood cultures are positive
for bacteria in about half of patients. Percutaneous
aspirates from the abscesses are positive for bacteria in
about three-quarters of patients .13 Aspirat i ng a
pyogenic liver abscess reveals a malodorous exudate.?
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The clinical syndrome of a pyogenic abscess often
cannot be distinguished from that of an amoebic
abscess. Since aspiration of an amoebic abscess can lead
to secondary infection, especially in geographic areas
with a large immigrant population, eliminating this
possible diagnosis is important. Appropriate serologic
tests such as the indirect hemagglutination test are
useful in the diagnosis of an amoebic abscess.14
In addition to clinical findings, and altered
biochemical levels, a number of imaging techniques are
available which may aid in the diagnosis of pyogenic
hepatic abscess. These techniques include ultrasound,
computed tomography, invasive techniques, plain
radiographs, and radionuclide isotope scanning.
Ultrasound has an 85-95 % sensitivity for th e
detection of hepatic abscesses and is the most u seful
screening test when an hepatic abscess is suspected.
Ultrasound is cost-effective, more accu rate than CT in
imaging the biliary tree, and allows for diagnostic or
therapeutic drainage or biopsy to be performed during
the scan. Ultrasound may also be used intraoperatively
to locate small or deep abscesses in the liver. 15
Ultrasound, however, may fail to detect an abscess in a
liver that is inhomogeneous or high beneath the
thoracic cage.
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Table 1

TREATMENT

Drug Therapy for Pyogenic Hepatic Abscess
Pathogens

Antibiotic Agents

Gram-negative rod (44%)
Escherichia coli
Klebsiella pneumoniae

Treat with ingle agent:
Ampicillin- ulbactam (Unasyn)
or
Ticarcillin-potas ium clavulanate (Ti mentin)
or
lmjpenum-cilastatin (Primaxin)

Gram-po itive cocci (40%)
Streptococcus spp.
Staphylococcus spp.

Treat with two agents:
Second- or third-generation cephalo pori n plus
metronjdazole (Fiagyl) or clindamycin (Cleocin)
or
Ampicillin plus chJorampherucol (ChJoromycetin)

Anaerobic organi m (8%)
Bacteroides spp.
Clostridium spp.
Peptostreptococcus spp.

Treat with three agents:
Ampicillin or antip eudomonal perucillin plus
a econd- or third-generation cephalo porin or an
aminoglycoside plus metrorudazole or clindamycin

Microaerophjlic
organism (6%)
Streptococcus milleri
Streptococcus mitis

U e arne treatment as for anaerobic organi ms

Computed tomography (CT) is the diagno stic
technique of choice. Its sensitivity is 95 %, and its
specificity is 92 % for si ngle abscesses and 100% for
multiple abscesses.16 When used with contrast, CT will
show the relative hypovascula rity a t the location of the
abscess. CT also allows for simu ltaneous diagnostic or
therapeutic intervention.
Endoscopic retrog rade cholangiopancreatography
(ERCP)
and
percutaneous
tr a n s hepati c
chola ngiog raphy (PTC) are invasive techniques which
are useful if biliary obstruction and ascending
chola ngiti are suspected . The e carry the ri sk of
dissemination of infection . Angiography involves
fewer complication and ma y be 100% se nsitive for
detection of hepatic abscesses.1 7
Chest x-ray is abnormal in about half of patients, but
is neither ensitive nor specific fo r pyogenic hepati c
abscess.1 8 X-ray ma y s how right hemidiaphra gm
eleva tion, pleural effusion, and basilar atelectasis o r
infiltrate.14 A plain abdominal film may show gastric
displacement due to liv er enla rgem e nt1 8, and
occasiona lly an air-fluid level in the region of the liver,
representing an abscess.
Radionuclide isotope scanning uses labelled tracers
that are concentrated
in h e patoc y te s or
reticuloendothelial cells. The e scans are 80-90 %
sensi tive, but are unable to d etect small lesions and are
unable to discriminate bet wee n solid and cystic
tructures.1 7, 19

The treatment of the
abscess includes intravenous
antibiotics and drainage .
Treatment
should
be
indivi dualized for each
patient.
Antibiotics should be
give n immediately, by the
parenteral route, starting with
a broad coverage regimen
consisting of a penicillin, an
aminoglycoside,
and
clindamycin or metronidazole. Adjustment of thi s
regimen depends on culture
results of abscess aspirates
(see Table 1).6 If cultures are
sterile but a clinical diagnosis
of h e patic abscess remains ,
broad-spectrum antibiotics
sho uld
be
maintained .
Antibiotics should be given
for at least three weeks20;
some physicia ns recommend
therapy for up to 12 weeks.
Antibiotics hould be given

CLINICAL ASSISTANTS
MEDICAL ONCOLOGY
Applications are invited for a position available from the 1st
of February 1994, as full time Clinical Assistant in Medical
Oncology at the London Regional Cancer Centre (LRCC).
Principal duties will include outpatient clinics and inpatient
care under consultant supervision. The successful applicant
will join a junior staff of 3 full time clinical assistants, 3
medical oncology residents/fellows, and rotating staff in
radiation oncology , hematology , and gynecolo gy .
Postgraduate education program opportunities are
available. Applicants must possess or be eligible for general
license in Ontario. A 12 month minimum appointment is
preferred.
This is a salaried position with an attractive benefits package
and paid vacation .
Applications with curriculum vitae and the names of two
referees should be sent to:

Dr. Vivien Bramwell
Chief of Medical Oncology
London Regional Cancer Centre
790 Commissioners Road East
London , Ontario, Canada N6A-4L6
For further information, telephone (519) 685-8639.
Closing date for application: 15th of December 1993.
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for 1-2 days before drainage is begun2. Oral therapy
may be u ed in the final week or two of treatment if
clinical improvement continues. Antibiotic trea tment
alone, without drainage, has been referred to in the
past as a "last resort" in the primary treatment of these
abscesses, and several studies proclaim its
inadequacy.2,13,15 Recently, however, that drainage is
necessary only if the pati e nt does not respon d to
antibiotics within 48 hours , or if the patient
deteriorates clinically, has been suggested.21 In the
case of microabscesses, where drainage is difficult by
any method, antibiotics alone are the mainstay of
therapy . Monitoring the efficacy of antibioti c-only
treatment, by sizing the abscesses using re peat
ultrasound imaging, is imperative.
In addition to antibiotics, drainage of the abscess is
also critical to a successful treatment outc ome .
Drainage may be percutaneous or open. Two d ecades
ago, open drainage was much more common than
percutaneous drainage as a primary therapy. Through
the 1980' s, the two were performed on an equal basis?
Percutaneous drainage became more popular in the
late 1970' as an adjunct to open drainage and as a
primary treatment. Percutaneous drainage is the
current "gold standard" for diagnosis of a pyogenic
hepatic abscess, 6 and is 86-92 % s uccessfu l as a
treatment. Percutaneous drainage involves first

localizing the abscess under ultrasound or CT
guidance. A tract to the abscess is then produced using
a needle, guide wire, and dilator; a drainage catheter is
subsequently inserted into the cavity. Such a catheter
would be left in place for 2-3 weeks; early removal is
associated with recurrence of abscesses.22 This type of
drainage may be used as definitive therapy, or preoperatively before open drainage either if the patient is
not responding to antibiotics or a search for the
primary site continues. The percutaneous method of
drainage is ideal for abscesses which are solitary,
accessible by needle, deep-seated, or adherent to the
abdominal wall? With this method, however, there is
an increased likelihood of secondary procedures; as
well, the underlying source of the abscess may remain
unknown. Further, failure of this method may result if
the abscess is multiloculated, if its contents are too
viscous to drain via a catheter, or if the catheter is
dislodged from the abscess.23,24
Open drainage is the classical treatment of liver
abscesses . This method is ideal for concurrent
drainage of another (e.g. appendiceal) abscess,
drainage of multiloculated abscesses, or those that are
not easily accessible by needle . Open drainage is
usually undertaken on a patient after the percutaneous
method had failed2. Open drainage is associated with
a highe r rate of complications and mortality. Thus,
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raw co mpari s on s of s urgical ve rsus percutaneou s
treatment are not appropriate without consideration of
underlying conditions and location and accessibility of
ab cesses . Complications include se pticemia (most
commo n ), effusions, emp ye m a, rupture into right
ubphrenic s pace, and pneumonia.? Three methods of
open drainage exist: the transpleural approach, which
is usefu l for high posterior lesions; the transperitoneal
approach, which is the most preferred method since it
allows inspection of the entire abdominal cavity for an
underlyi ng source, a nd provides the best mobilization
of o r ga n s for drainage ; and th e extraperitoneal
approach which may begin posteriorly near the 12th rib
or via an anterior retroperitoneal dissection.2
Recent s uggestions16 for treatment have included
the use of laparoscopic investigation for liver abscesses.
Many patients with liver abscesses, however, hav e
dense right upper quadrant adhesions or abscesses,
which would preclude s u ccess ful laparoscopic
aspiration. Resection of a portion of liver containing an
abscess or ab cesses is reserved for areas of infection
econdary to hepatic malignancy, or those associated
with granulomatous disease of childhood .2
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DIAGNOSIS AND TREATMENT
OF SEPTIC ARTHRITIS
by Janet Pope, M.D., MPH, FRCPC

ABSTRACT
'he causative agents, demographics and outco me of
septic arthritis have changed over the last several
years. Staphylo cocc us aureus remain s th e most
common cause of septic arthritis caused from nongonococcal
organisms. M eth icillin -res istant joint infection s with
Staphylococcus aureus have been increasing. Due to better
culturing methods more anaerobic cases of septic arthritis
are being identified. The most common joint in volved in
septic arthritis in adults is the knee. However, there are
exceptions in certain populations. Intra venous drug use is a
risk factor for se ptic arthritis, often in vo lv in g
fibro cartilaginous joints such as the sternoclavicular and
sacroiliac joints. The outcome in these patients is usually
excellent. The fun ctional outcome of a septic joint is usually
good if the diagnosis is made within two weeks of disease
onset. The morbidity with gram negative bacteria is usually
higher than with gram positive cocci. Debate about when to
interve ne surgically in the treatment of septic arthritis
continues.

T

INTRODUCTIO N
There has been little change in the total number of
cases of bacterial arthritis1 but certain infections are
increasing such gram negative bacilli and non-group A
streptococci, whereas pneumococci are relatively rare
in septic arthritis now. Anaerobes have been cultured
more frequently which may reflect better culture
techniques. Within certain populations, there may be
specific types of bacterial infections, su c h as
Staphylococcus aureus (S. au reu s) and pseudomonas in
intravenous drug users. So far, there have not been
observations of increased septic joints in HIV positive
patients, but with AIDS becoming a more chronic
disease, it may be tubercu lous arthritis or other
atypical bacterial joint infections may increase in this
immunocompromised population. Bacterial arthritis is
the most rapidly destructive form of arthritis. There
are two major types of bacterial arthritis: arthritis from
Neisseria gonorrhoeae and other bacterial arthritis.
The former arthritis is usually more benign and will
not be discussed in this review. The pathophysiology,
diagnosis and treatment of septic arthritis is discussed.
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PATHOPHYSIOLOGY
Mos t cases of septic arthritis have resulted from
bacterial hematogenous spread . Fewer cases occur from
direct spread from joint trauma, arthrocentesis, or local
osteomyelitis. Within two days after injection of S.
aureu s into a rabbit joint, polymorphonuclear
infiltration and synovial lining cell hyperplasia occurs.2-4
Chondrocyte necrosis can occur in two days. Abscesses
develop within the joint space. Irreversible joint
destru ction can occu r as early as one week after the
onset of infection.
Joints that are damaged are predisposed to infectious
arthritis. Rheumatoid arthritis is a risk factor for septic
arthritis, as is gout, chondrocalcinosis and
osteoarthritis. Intravenous drug abusers are at risk due
to recurrent bacteremia. People with sickle cell disease
are at risk for certain types of infections including
salmonella osteomyelitis or septic arthritis. O thers with
chronic disease who are immunosuppressed are at an
increased risk. These include people with systemic
lupus erythematos u s, cancer, alcoholism and renal
transplantation . The very young and old are at an
increased risk of septic arthritis due to impaired host
defenses.
The joints commonly involved in adults are the knee
and the hip. Children also have these joints involved
but have bacterial hip arthritis slightly more often than
what occurs in adulthood . See Tab le 1 for the
frequencies of joi nt involvement. Eig h ty to ninety
percent of septic arthritis is monoarticular. In those
with more than one joint involved, the most common
organism is still S. aureus and then streptococcus

Table 1
Joints involved in Septic Arthritis
Percentage of Cases
Joint
Knee
Hip
Ankle
Shoulder
Wrist
Elbow
Others
More than one joint

Adult
55

Children

11

28
14
4

8
8

40

7

3

6

11

5
12

3
7
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limited passive a n d active ra nge of
motion.
The mortali ty rate is doubled
Table 26
in
those
with
polyar t icu lar
Organisms in Septic Arthritis
involvement.S Most patients a r e
febrile . The differe ntial diagnosis
Children(%)
Adults( %)
includes
o t her
infla m mato r y
Gram Positive Cocci
arthropathies. See Table 3 for a list of
differential diag noses. On physica l
27
S.aureus
35
examination,
a source of the infection
16
10
S. pyogenes, S. pneumoniae,
should
be
looked
for as most of the
S. viridans Group
cases are from hematogenous spread.
GramNegative Cocci
In children, otitis media and
8
gonnorrhoeae and meningitidis
50
meningitis should be ruled o u t if H .
H. influenzae
<1
<40
influenza is suspected. Over half the
patients with septic arthritis have a
Gram Negative Bacilli
peripheral leukocytosis.? Both blood
E coli, Salmonella and
and synovial fl u id cultures are
9
Pseudomonas species
5
important for diagnosis.
Blood
cultures which are positive in 30 to
Mycobacteria and Fungi
<1
<1
60 %8,9,10 of cases should be done.
Cultures of other areas such as urethra
and cervix are importan t to rule out
pneumoniae (S. pneumoniae), group G streptococci and
gonococcal infection . Any symptomatic areas should be
Haemophilus influenzae (H. influenzae).S
cultured such as sputum if the patient has pneumonia,
Aside from is eriae gonorrhoeae ( . gonorrhoeae),
and urine and skin ulcers where indicated . Baseline
radiographs should be done. The presence of an
the most common cause of septic arthritis is S. aureus
effusion i common but erosions are not usually seen
which occurs in approximately 70% of other bacterial
arthritis in adults and 27% of childhood cases.6 Young
early on radiographically. The joint should be aspirated
and fully drained.
children less than five years of age are at risk for H.
Synovial fluid is often cloudy. The fluid should be
influenzae which is frequently accompanied by
concurrent infection such as otitis media or meningitis.
ent for gram stain, culture and sensitivity, acid fast
Other gram negative organisms occur rarely in septic
culture w here indicated , white blood cell count and
joints. However, intravenous drug abusers are at an
differential, red blood cell count, and crystal analysis.
increased risk of S. aureus in orne East coast cities and
The gram stain is positive in 50 to 60 % of
nongonococcal septic arthritis_8,11 ,12 The white count is
p eudomonas in the western United States and in
Detroit. Table 2 lists the prevalences of certain bacterial
greater than 50,000/mm3 in 70%.13 The presence of red
blood cells in a joint with no history of trauma is
pathogens in adults and children w:ith septic arthritis.
correlated with an increased risk of septic arthritis .
Therefore, any bloody synovial fluid should be sent for
DIAGNO SIS
culture. The p resence of crystals does not rule out
A septic joint usually pre ents with an acute tense
septic arthritis. Acute gouty arthritis can also have high
effusion, warmth, erythema, inten e pain and markedly
white counts, o the diagnosis of septic arthritis should
be entertained in a patient with gout who is having an
ac ute flare-up .13 Polymorphs are abundant with a
sy novial fluid differential of greater than 80 % and
Table 3
usually greater than 95% polymorphs are seen. 13
Differential Diagnosis of Bacterial Arthritis
The synovial glucose i often les than half of the
se rum glucose .14 However this is not definitive as
several patients with rheumatoid arthritis have a low
Gout
glucose. This test is also not sensitive. If the diagnosis
RA
of
septic arthritis is uspected but not confirmed by the
Lyme Disease
u
ual
te t , then it may be worthwhile to do a gallium
Viral Arthritis
scan which if negative, rules out eptic arthriti .
P eudogout (Chondrocalcino is)
Us ually this is not necessary. Gallium scans are
Reiter's Syndrome
sensitive in detecting septic arthritis but are not specific.
Acute Tramatic or Hemerrhagic Arthritis
Other imaging modalities are usually unnecessary for
Bacterial Endocarditis w:ith Embolization
the diagnosis of septic arthritis.
Rheumatic Fever
Osteomyelitis ear Joint
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TREATMENT
Treatment is both local and systemic. A septic joint
should be repeatedly aspirated as th e effusion
reaccumulates. Subsequent fluid gram stains, cultures,
white counts and percent polymorphs should be
followed and improvement implies successful therapy.
The joint is rested with initial passive range of motion a
few times a day. There should be no weight bearing for
several days. The joint may be splinted, but not in a
flexed position or the chance of a flexion contracture
occurring is increased. Systemic high dose antibiotics
are given often for up to four weeks in nongonococcal
bacterial arthritis. Table 4 lists possible antibiotic
choice to initiate according to the gram stain and the
patient' s demographics.
There is debate in the literature about when surgery
should be the initial treatment for septic arthritis. Any
joint which is difficult to aspirate and to follow
clinically, should be treated with urgical drainage.
Septic hips are often drained fluoroscopically or by
ultrasound guidance in children. If gas forming
bacteria are seen on radiograph, this would be an
indication for urgent surgical debridement. A postoperative drain is usually inserted . For the surgical
treatment of septic arthritis, arthro copically drained
joints are being performed commonly now and open
arthrotomies are decreasing. Failure of a ntibiotics
(persistently positive joint cultures) is an indication for
su rgery. Many of these cases have small synovial
abscesses for which a partial synovectomy is
performed. In a review of the case series i n the
literature, Goldenberg et al found that 80 % of patients
treated medically had complete recovery compared to
47% with surgical treatment.1 5 There may have been
selection bias where only sick patients with more severe

infections were treated surgically. However, because
there are no randomized trials comparing surgical to
medical treatment, this is the best information to date.
Therefore, in most cases of septic arthritis, the initial
treatment is medical.
Delay in antibiotic treatment is proportional to poor
outcome.8 If antibiotics are begun within two weeks,
67 % of septic joints were found to have complete
functional recovery. Whereas, only 27% of joints had
complete functional recovery if treatment was initiated
more than two weeks after the onset of symptoms .
Mortality rate in septic arthritis is increased in the
elderly (up to 25 %), in those with several joint
involved and in those with comorbidity.11 ,16 Several of
these risk factors for poor outcome are correlated .
Functional recovery is decreased in gram negative
arthritis compared to gram positive. Intravenous drug
abusers who are otherwise well have an excellent
recovery in general and may only require therapy for a
couple of weeks. These patient are often otherwise
young and healthy and have only transient bacteremia
with a less severe form of septic arthritis often in small
fibrocartilaginous joints such as the sacroiliac joint. A
short duration of treatment is usually successful in
eradicating the infection; this is fortunate since
compliance can be poor.
Sequelae of septic arthritis include flexion
contractures, ankylosis, erosive arthritis, sterile postseptic synovitis, decreased range of motioQ of the
involved joint and local muscle wasting . Rarely
osteomyelitis occurs secondary to an adjacent septic
arthritis.

SPECIAL CONSIDERATIONS
GRAM

Table 4
Examples of Empiric Antibiotic Treatment
Gram Stain

Treatment

Gram Positive Cocci

Cloxacillin
Vancomycin
Cephalosporin
Pipercicillin and Tobramycin
Moxalactam
Cefotaxime
Ampicillin
Cefotaxime
Penicillin (N Gonorrhoeae)

Gram Negative Bacilli

Gram Negative Coccobacilli

Total Joint Prosthesis
(Irrespective of a Gram Stain)
No Organisms on Gram Stain
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Vancomycin and Gentamicin
Cloxacillin and Aminoglycoside
Cefazolin and Aminoglycoside
Cefotaxime

EGA TIVE SEPTIC ARTHRITIS
There are four groups who are at risk for
gram negative septic arthritis. Infants less than
two months are susceptible to gram negative
bacteremia and can develop sep ti c arthritis.
Young children have an increased incidence of
H. influenza infections. There has been some
ampicillin-resistance of H . influenza over the
last decade, so the initial treatment for this
infection is often with a third generation
cephalosporin. With the vaccination against H.
influenza now being widely administered to
children in the first year of life, H. influenza
septic arthritis could become quite rare. The
elderl y, es p ecially those with underlying
arthritis have an increased risk of acquiring a
gram negative joint infection often from
urinary tract infections or diverticulitis with
septicemia. In some areas, intravenous drug
users have pseudomonal infections. The
immunocompromised are at increased risk for
bacterial joint arthritis including gram negative
infections.
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RHEUMA TOlD ARTHRITIS
Pa tients w ith rhe uma toid a rthriti s (RA ) a re a t a n
in c r eased ri s k of se ptic a rthr iti s. Th e s ig n s a nd
sym p toms of septic arthritis could be masked in these
patients due to their underlyi ng arthritis, use of steroid s,
and d e bilita tion . In RA , 50 % of p a ti e nts h ave a
perip hera l le uk ocy tos is.? Th e m os t common joint
involved is s till th e kn ee (50 % to 75 % in ca ses
eries),17,18 howeve r th e e lbow is a lso fr e qu e n tly
involved (13 to 38% of cases of septic arthritis in RA).
There is an increased tendency fo r multiple joints to be
involved ,19-21 and in one series, 70% had polyarticular
sep tic arthritis.22 Most septic join ts in RA originate from
bac te r e mi a . Th e dia g no sis is s u s pec te d wh e n
in fla mmation and pain are g rea te r than the patient's
other joints. The causative orga nism is still most often S.
aureus, occurring in over 80% of cases.8,9,12,19,22-24 The
synovial fluid white cell count may delay the d iagnosis,
as 4% of p a tie nts with RA witho ut an infection may
have a white count of greater than 50,000 / mm3.

thera py sho uld be performed using knowled ge of the
loca l e nd e mi c bacte ri al p reva le nces and resis tances.
The prognosis is good in most cases if antibiotic therapy
is initia ted promptly.
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O T I T I S M E D IA

IN

CHILDHOOD
by Michael]. Rieder, MD, PhD, FRCPC

INTRODUCfiON

O

titis media is a common problem presenting to
primary care and emergency physicians. In
Canada, the most frequent diagnosis for which
antibiotics are prescribed among pre-school children is
otitis media. Up to 20% of all visits to primary care
physicians in Ontario are for the therapy or follow-up
of otitis media. Thus primary care physicians should be
comfortable with the management and follow-up of
otitis media.

PATHOPHYSIOLOGY
Acute otitis media is an infection involving the
middle ear, usually of bacterial origin. Among
toddlers, this infection is commonly related to
Eustachian tube dysfunction. Eustachian tube
dysfunction is more common among toddlers for a
number of reasons, including the relatively horizontal
location of the Eustachian tube in young children and
the relatively large size of periadenoidal lymphatic
tissue. Eustachian tube dysfunction is also common
after upper respiratory tract infections. In addition,
there are some groups, such as children with Down' s
Syndrome, who are at high risk for Eustachian tube
dysfunction.
There are three bacterial species commonly found
among children with acute otitis media; Streptococcus
pneumoniae, Haemophilu s influenzae, and Branhamella
catarrhalis. Among these organisms, there are
appreciable rates of beta-lactose activity among
Haemophilus influenzae and Branhamella catarrhalis.
Otitis media caused by Haemophilus influen zae is
relatively more common among infants and toddlers.

PRESENTATION
There are three principle presentations of bacterial
otitis media, acute otitis media, resistant otitis media,
and recurrent otitis media. The first, and most common,
is acute otitis media, in which a child develops an acute
bacterial infection in the middle ear (often after a viral
upper respiratory infection). This acute presentation is
manifested clinically as pus in the ear, often associated

with fever and occasionally accompanied by vomiting.
The natural history of acute otitis media is that, if
untreated, the vast majority of these infections will
resolve, often after rupture of the tympanic membrane.
However, without antibiotic therapy, children tend to
have somewhat longer periods of pain and distress than
when treated. In addition, the complications of acute
otitis media, including meningitis and cholesteatoma
formation, appear to be much more common among
untreated children.
After antibiotic therapy is instituted, a clinical
response is anticipated in 24 to 48 hours. If the child
has not improved, or if the child deteriorates, then the
child should be considered to have resistant otitis
media. In this type of presentation, the child's otitis
media is likely caused by an organism resistant to the
antibiotic prescribed.
The final presentation of otitis media is that of a
child whose otitis media responds to therapy, but,
shortly after therapy ends, another episode develops.
In this case, the child has recurrent otitis media .
Recurrent otitis media may be due to the presence of
special risk factors for otitis media, such as Down's
Syndrome, allergies, or adenoidal hypertrophy.
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recurrent
otitis
media.
Recurrence and frequency
warrant consider-ation for lowAntibiotic Doses for Otitis Media
dose prophylactic antibiotic
therapy or for surgical
Frequency of
placement of myringotomy and
Daily Dose
Administration
tympanos-tomy tubes. The
only antibiotics which have
amoxicillin
25 mg/kg/ day
3 times per day
been evaluated in this role have
been amoxicillin and co2 times per day
co-trimoxazole
TMP 6 mg/kg/ day
trimoxazole . Hopefully, the
development of vaccines may
erythromycin/ suliamethoxazole eryth: 40 mg/kg/ day 3 times per day
resolve
some
of
these
(Pediazole)
therapeutic dilemmas.
2 times per day
pivampicillin
50 mg/kg/ day
Antipyretic
and
analgesic
therapy
is
important
3 times per day
amoxicillin/ clavulanate
20 mg/kg/ day
in the symptomatic therapy of
otitis media. Acetaminophen is
3 times per day
cefaclor
25 mg/kg/ day
the mainstay of therapy in a
1 time per day
8 mg/kg/day
cefixine
dose of 15 mg/kg/dose given
every 4 hours as needed. In the
unusual case where a child
THERAPY
who has had adverse reactions to acetaminophen ,
naprosyn 20 mg/kg / day divided into two to three
The mainstay of therapy for acute otitis media is the
doses a day can be used . For single-dose therapy
use of oral antibiotics. Traditionally, the use of an
immediately after diagnosis, a single dose of 1 mg/kg
aminopenicillin drug such as amoxicillin has been the
of codeine can be used.
usual first-line therapy for otitis media (see Tables 1
Patients with acute otitis media should have clinical
and 2) . In the case of penicillin-allergic patients, coimprovements in 24 to 48 hours. If the patient has not
trimoxazole (Septra or Bactrim) or erythroimproved at that time, or if the patient deteriorates, the
mycin / sulfamethoxazole (Pediazole) should be used.
patient should be seen again. If the patient's symptoms
For resistant otitis media, an antibiotic should be
resolve, the patient should be seen in follow-up in two
chosen which has a different bacteriological spectrum
to three weeks. A sterile effusion may persist for up to
from the antibiotic originally prescribed . There are a
six weeks after as episode of acute otitis media. Fluid in
number of antibiotics available as secondline therapy,
the middle ear that is not associated with symptoms
including cefaclor, cefixine, amoxicillin/ clavulanate, comay not require therapy, but it does need follow-up,
trimoxazole and erythromycin / sulfamethoxazole.
especially with respect to the potential for hearing loss.
The same consideration for changing antibiotic
In the case of recurrent otitis media, follow-up will
therapy apply in the case of the acute therapy of
have to address the potential need for insertion of
tympanostomy tubes.
Table 1

Table 2

Cost of 10 Days of Therapy (10 kg child)
Cost of D rug

Dispensing Fee (Average)

amoxicillin

2.19

10.00

co-trimoxazole
(Septra, Bactrim)

1.59

10.00

10.99

10.00

pivampicillin

9.57

10.00

amoxicillin/ clavulanate

7.75

10.00

cefaclor

11.43

10.00

cefixine

14.58

10.00

erythromycin/ suliamethoxazole
(Pediazole)
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SAMPLE OF INFECTIOUS DISEASES
RESEARCH IN PERU
by Ross Mantle, BSc, Meds '95

he following is a sample of eight concurrent research
projects I was exposed to when I travelled to Peru in
the summer of 1992 and s tayed with Professor
Robert Gilman, MD of John's Hopkins University. Dr.
Gilman has lived in Lima for eight years engaged in
research and publishing papers. In addition to Hopkins,
Peruvian universities Universidad Peruana Cayetano
Heredia, and Universidad San Marcos arecentres that
have been associated with work in infectious d iseases.
Also involved is Prisma, a well established third world aid
and development organization supported in large part by
American grants and directed by Dr. Gilman's wife . The
wide diversity of tropical infective disease, coupled with
the effects of altitude which can be observed in the Andes
make Peru an atractive research arena for the infective
disease specialist.

T

Helicobacter pylori (HP)
The relationship between HP, atrophic gastritis, and
gastric ulcer has been known for over five years, but is
only just now becoming accepted in North American
Centres. The further likely relationship between HP and
gastric cancer is the subject of resea rch effort by Dr.
Gilman. In the third world HP infection rates typically see
most of the population infected by age 20, and in some
places 50% of the population are infected before one year
of age. Rates of gastric cancer are higher and those of
peptic ulcer lower than in the first world.

Cyclospora cayetanesis
A new enteropathogen first described by Dr. Gilman's
group which is named after Universidad Cayetano
Heredia. Work has begun on basic epidemiology and
serology.

Cryptosporidium
Cryptosporidium is also an enteropathogen, but not
fatal. Nevertheless, work on nutritional s tatu s and
diarrhea due to cryptosporidium has revealed changes in
growth patterns.

Oximetry
A very useful means of determining repiratory
decompensation in children with upper respiratory tract
infections living at high altitude. Because the ambient
oxygen tension is so low, patients reach the steep portion
of the oxygen saturation curve earlier. O xi metry in
combination with the World Health Organization (WHO)
algorythmare a very powerful diagnostic tool.

Tuberculosis
Patterns of endemicity with respect to age differ in the
third world from what might be expected in more
developed areas. Dr. Gilman's group is working on a
mathematical model of the epidemiology of this condition.

Cholera
Inca Peanut
Over a year and a half of water and sewage sampling
has provided support for the use of sewage monitors to
predict cholera outbreaks. Also bioimpedance monitoring
has allowed better determination of the state of hydration
of cholera patients, allowing for more effective
rehydration. 1

Cysticercosis
Western blot techniques have shown that over 10% of
Peruvians and 25% of pigs hae antibodies to T. solium.
Current studies are examining the use of sentinel pigs to
detect infection in endemic zones. Cysticercosis may be a
causative factor in the development of epilepsy.

46

Not an infectious disease, but a potentially useful and
valuable plant. The Inca peanut, or oilseed Plukentia
volubilis was used to make oil by the Inca Indians .
Research by Dr. Gilman's groups in collaboration with the
University of Arkansas has revealed that the fruit has very
high ratios of low saturated fats. Also, the high protein
content is a rich source of essential amino acids. Vitamin E
content is also high.
REFERENCES
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STITCHES IN T I M E I I
MISADVENTURES IN PSYCHIATRY
by W. David Colby, MSc, MD, FRCP(C)

f you asked me, as a first year medical student, what
branch of medicine I planned to undertake, I would
have unhesitatingly said "Psychiatry". The idea of
flailing at the frontiers of the human psyche was
unbelievably enthralling. Delving into the processes,
emotions, and even the chemistry of what makes us
unique sentient beings (at least in some cases) probably is
the most interesting aspect of medical practice. I read the
works of Freud, Bettelheim and Brenner and just couldn't
wait for my first assignment at 999 Queen Street East,
probably the most famous cookie jar in Ontario. I knew
that things there would probably be a little bit on the
gritty side because, after all, the truly erudite
psychoanalytic types carried on their practices at the
elegant Clarke Institute of Psychiatry. Nevertheless, I
was looking forward to a calm cerebral experience
delving into why a patient thought he was Napoleon, or
orne other equally fascinating delusion.
I was first greeted by the resident who explained the
ground rules . "Whenever you are interviewing a
patient, make absolutely certain that there is a
telephone in the room", he explained.
"How often do you have to call for help?" I asked.
He gave me the strangest look.
"You don't call for help", he said with a note of
bored sarcasm. "If they give you trouble you pick up
the phone and smash them in the face with it." He
walked out shaking his head and I meekly followed.
We walked into a patient room where there awaited our
first subject. He was a small furtive man with greasy
hair and eyeglasses that were at least four sizes too
large for his face, which created a distinct owl-like
expression. He was chain-smoking cigarettes and there
was a large filthy ashtray in front of him, full of the
detritus of his habit. What a pitiful-looking individual,
I thought. A number of diagnoses went through my
mind-neurotic?
obsessive-compulsive?
chizophrenic? forensic case? My thoughts were
interrupted by his outburst.
the staff psychiatrist. You
"Hello, I'm Dr.
must be the new medical student."
Things didn't go so well during this rotation,
although I must admit we did see a number of
interesting patients. There was a fellow who thought
he could identify different neighbourhoods and cities
by their characteristic sounds and gave beautiful
descriptions of the music in the air composed of city
noises . There was a fellow who was trying to
enumerate the number of ants in Canada. "I know it
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ounds strange, but there i a way to do it!" Another
one thought he was Jesus Christ and assigned biblical
roles to all the significant people in his life. What he
worried about was having to relive the crucifixion scene
since it was so rough the first time. I felt quite sorry for
him. My favourite was this fellow who sat around all
day in a black depression doing nothing but moping
around the house and watching television. "What kind
of shows do you watch?", I asked.
"Happy Days", he replied . He went on to describe
how he finally decided to end it once and for all by
slitting his throat with a butcher knife. " ... and I laid
down and waited to die", he said, " ... but I didn't die, so
I called the ambulance."
"Why did you call the ambulance if you wanted to
'"Cause I didn't
die?", said the other clinical clerk.
want to get an infection, you stupid idiot."
I just couldn't do anything right as far as my staff
psychiatrist was concerned . At the end of the year, he
kicked me out with one point above a bare PASS level.
Needless to say, the very next week my first rotation as
a clinical clerk at another hospital was in Psychiatry,
and with the same approach and skills, I achieved the
highest grade awarded that year on that service. Most
of the staff psychiatrists were very interesting and had
genuine, deep insight into the human mind. My
favourite was an elderly fellow whom I will call
" utty ". During his prime, he had achieved
considerable fame for his skills as a diagnostician and
therapist and even in his post-retirement capacity- this
guy missed nothing. He may have achieved this insight
by spending long periods of time as an inpatient on the
Psychiatry Service where he worked. Whenever he felt
that he was losing it, he would conveniently admit
himself under himself, write his own orders and treat
himself until he felt he should be discharged, all the
while leaving his bed periodically to do rounds on his
other inpatients on the same service! I left that service
with great reluctance because, unlike my experience at
Queen Street, I had learned a great deal. Unfortunately,
I also learned about the most unpleasant type of
psychiatric patient-one whose mere mention sends
chills up the spine of any practicing psychiatrist: the
borderline personality disorder.
Patients with borderline personality disorder seem to
have been placed on this earth for a specific mission: to
make the lives of their therapists miserable. They are
equipped with every nasty psychological trick in the
book: sharply opinionated nature, exaggerated
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emotional responses and an ability to incite conflicts
wherever they go. Many of these people, of course, end
up serving in public office. I will present a brief case
history of a typical patient which I saw in my phase of
being an Emergency physician.
I looked down on the chart and saw that the chief
complaint of this patient was "wants to talk to a
doctor" . I knew that spelled trouble. It wasn' t a good
day anyway as I had 75 patients backed up in the
waiting room. Nevertheless, I dusted off m y best
"doctor-patient relationship hat'', put it on and went in
to see the patient. She was a nurse in her early 60s.
"Hello, Mrs.
I'm Dr. Colby. What is
troubling you today?"
"You' re th e doctor. You tell me! " , she sneered
through a Medusa's breath of venom.
"Oh, no!", I thought, " ...1 can' t stand it. Furthermore,
I don' t have time for this." Nevertheless, the patient
went on a long rambling narrative about how she had
been prematurely widowed, had been alone for many
years but had presented to the Emergency Room
because she now had a boyfriend who cared about her.
"Say what?" , I thought. "Are you having a problem
with your relationship?", I asked.
"Of course I am!", she screamed . "The relationship
ha s progress ed to the point of where it' s g e tting
physical and it makes me nervous. Do something about
it!"
Great. An emotional adolescent lands on my
doorstep expecting long-term psychotherapy to start in
the middle of the busiest afternoon in my life and is
hostile besides. I considered handing in my resignation
and walking out but I thought I could probably be sued
somehow for this. Just when I was about to sign myself
in as a patient, what did I hear but the voice of the
consulting psychiatrist on call, walking by just outside
the confines of the Emergency cubicle. I shoved my
hand through the curtains, found a lapel and dragged
him in . "Dr.
, I'd like you to meet Mrs.

Jason Bowels M.D..

_ _ _ __ _ . She has a problem and I would like to
refer her to you." This was a classic dump, elegantly
executed. The timing couldn't have been better. A few
patients later, I noticed out of the corner of my eye Mrs.
________ sashaying out of the hospital with a
prescription in her hand. I was then summoned to the
other hospital in town since there had been a multiple
motor vehicle accident resulting in a large number of
critically injured patients s uddenly arriving at th e
Emergency Room and overwhelming the staff there. I
jumped into the car and roared across the river to the
other hospital and attended a few of these unfortunate
accident victims. While I was writing at the chart desk,
whom should I see but Mrs.
coming in,
soaking wet, on a stretcher. The ambulance attendants
said that she jumped off the bridge and was fished out
of the river by a couple of guys angling from a boat.
"I'll handle this", I said to the chart clerk, and I
followed Mrs.
as they wheeled her into
the room. "Mrs.
why did you do this?"
"You should have seen the signs!", she hissed. "I'm
ready to be taken to my room now." She looked away.
I got the picture. This was an act of revenge for not
admitting her in the first place.
"But I did see the signs, Mrs .
", I
explained . " That' s why I referred you to Dr.
"Shut up and take me to my room", she said.
"I'll see to that when I can", I said icily and left her to
chill out for about 20 minutes . When I returned, I
informed that I had to do her admission physical.
While I was examining her, she suddenly put a satisfied
and triumphant look on her face. To my horror, I
realized that she had purposely voided her bladder and
bowels in order to make my job more unplea sant.
Borderline personality disorder.
It was at this point that I gave up any aspirations of
being a psychiatrist, forever.
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L i fegifts: The Real Story
Organ Transplants

of
by Sonny Bhalla

Calvin R. Stiller. 230 pp., illustrated. Toronto, Ont.,
Stoddart Publishing Co. Limited, 1990. $14.95.
ISBN 0-7737-2301-3.
r. Calvin Stiller's Lifegifts focuses on the sad
irony surrounding organ transplants: one
person's tragedy is another's good fortune. He
juxtaposes informational chapters about the state of
organ transplantation with anecdotal chapters that allow
the reader a glimpse of the complex emotions and issues
at the time of organ donation. This method of writing
allows Dr. Stiller to accomplish his goal "to help the
general public better understand the process and current
potential of transplantation while grasping the
correctable tragedy of wasted donor organs."
Dr. Stiller begins his discussion of the state of the art
in transplantation technology with a brief history of
organ transplantation. He simply and eloquently
describes the immune system, the problem of rejection in
transplants, and the effects of the introduction of
cyclosporine in 1978 on the success rates of various
procedures. Using a heart transplant as an example, Dr.
Stiller goes on to describe in fair detail the actual
technique in an organ transplant operation, and the
drama and sense of urgency throughout the procedure.
Despite his attention to detail, the discussion is absorbing
and the explanations are accessible to th e reader with no
medical training.
Far more important than the explanations about
technique or infrastructure is the author's discussion
about the attitudes and misconceptions on the part of the
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public and the medical community. Public education,
Dr. Stiller asserts, is essential to raise the percentage of
organs that are actually isolated and used.
A part of what makes this book so accessible to the
nonmedical reader is the author's willingness to
acknowledge the imperfections of the medical
community. Hesitancy on the part of physicians is a
significant obstacle that must be overcome before organ
transplantation achieves its full potential. Too often,
physicians view transplantation as an experimental
approach carried out in a few select sites across the
country. Nothing could be further from the truth; most
organs are transplanted with a full functional recovery
rate of 70-75 % or better. Doctors must be educated.
"Traditionally, doctors have been taught that their
responsibility for the patient ends at death."
Dr. Stiller is not afraid to comment on some of the
highly charged issues surrounding organ transplants.
Finally, Dr. Stiller discusses his vision for the future of
organ transplantation, and the obstacles that must be
overcome before we can finally cut short the tragic waste
of usable organs, and the consequent death of those who
desperately need them.
Overall, Lifegift s is a short, readable book that
concisely outlines the technological and psychosocial
issues regarding organ transplantation. The fact that Dr.
Stiller is acutely aware of the intense and often
conflicting emotions on the part of those considering
donation endears him to the reader, and therefore makes
his important message that much more effective.
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THINKING

ON

YOUR

FEET

"Thinking On Your Feet" is an exercise designed to test your clinical decision-making skills based on a case
presentation. Below is an exciting patient history with physical examination and laboratory results. Answers may be
found on page 53 & 54 or within the case itself. Although this section is called ''Thinking On Your Feet," thinking is
acceptable in any position. Answer the questions in sequence. Please do not peek at the answers prematurely-this
would not be ethical. Compare your responses with those of the case presenter. Award yourself one point for each
match.
Scoring:
85-100%
72-84%
59-71 %
40-58%

0-39%

Excellent. Patient is recovering nicely;
Strong Work. Patient is recovering-minor complications;
Good Eye. Patient likely to survive-some disfigurement;
Fair. Patient requires critical care & close monitoring;
Uh-Oh. Red alert-emergency crisis-check A-B-C's.

A CHILD WITH RECURRENT INFECTIONS
A nine year old girl presents with a diffuse papilliform
erythematous rash involving her trunk and extremities
includure her palms and soles. She is on treatment with
Septra for persisting, festering open sores on her
extremities, vulva and lower abdomen. Further history
reveals she had a severe pneumonia four months before
for which she was treated with antibiotics and
hospitalized for two weeks. She has had many previous
episodes of ear, sinus and chest infections since two years
of age but have been worst in the past year. She was born
with a congenital heart lesion and had open heart surgery
at one year of age. She was fully immunized, had no
delay in reaching her milestones and her height and
weight are on the 50th percentile.

4. What is your differential diagnosis?
5. Which laboratory investigations would be indicated?
6. What intervention would you offer this patient?

CONTINUES TO SUPPORT HOSPITAL PHARMACY

STOP PLEASE AND ANSWER THESE QUESTIO S:
1. What specific family history do you want to ask?
2. Which physical findings may you expect to detect?
PLEASE CONTINUE ...
On examination she is afebrile and in no acute d istress.
The erythematous rash is noted. She has numerous scars
and scabs on her legs and lower abdomen. There is
thrush in her oropharynx and she has only some minor
cervical lymphadenopathy. Her liver is palpabl 3 em
below the right costal margin and her spleen tip is also
easily palpable. She has a fixed splitting second heart
sound heard over her pulmonic area. The rest of her
examination is unremarkable.

MissisgugilfOn~rio

6600 Gor~~ Drive

STOP PLEASE AND ANSWER THESE QUESTIO S:

Corporate Office
14 5 Jules-leger Street
Boucherville. Ouebec. Canada
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3. What is your clinical diagnosis at this point?
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Fax: f5 14J 596-0003
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Canada: 1-aD0-263- 1780
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Problem

Solving

MEDICAL VOCABULARY
This section is designed to test and expand your knowledge of medical
terminology. How many items can you correctly define?
Scoring: [13-lS]=Superior knowledge, [10-12]=Above average, [8-9]=Adequate, [5-7]=Fair, [1-4]=Sub-par.
1. Refsum's Disease.
a) a ganglio ide storage disease producing a distinct maple
syrup odour to the urine;
b) th e di e a se complex which occ u rs s econda r y to
pinworm infection;
c) a ra r e degenera t ive disea se o f aging, co m monly
involving the speech centres initially;
d ) an a u to s oma l recessive, degenerative disorder
associated with retinitis pigmentosa, d ea fness, and
polyneuritis.
2. Indolent.

a)
b)
c)
d)

rude and insulting;
inactive, sluggish;
treacherous, stealthy;
insensible, unconscious.

Peristrumitis.
inflammatory condition of tissues around a goitre;
inflammation of a tendon sheath;
infla m ma t io n of m e mbra n e s a ro und a s inu s ,
especially a venous sinus of the dura mater;
d ) infla mmatory cond ition of the ex terna l layer of a
vein.

3.
a)
b)
c)

4. Frottage.
a) french cottage cheese;
b) the p u trid o d o u r pro du ced from th e co ll ec ti ve
decomposition of many corpses;
c) production of sexual excitement by rubbing against
someone;
d) reaking havoc.

5.
a)
b)
c)
d)

Oxyecoia.
having a sharp, pointed nose;
a genus of am oebas found in the intestinal tract;
excess of oxalate deposited in tissues;
abnormal sensitivity to noises.

8. Symphalangism.
a) the most anterior point of the alveolar p rocess of the
lower jaw;
b) web-fingered or web-toed condition;
c) excessive peripheral vascular tone due to sympathetic
d ysfunction;
d ) surgical repair of a divided symphysis.

Medicine
Get the facts about the challenge and oppor·
tunity of the Canadian Forces Medical Officer
Training Plan.
Students of medicine, male or female,
under the Medical Officer Training Plan, your
medical studies can be subsidized up to three
years at medical school and a maximum of two
years internship training. You will attend a
Canadian civilian university, your textbooks
and necessary equipment will be supplied
and you will be paid while you learn.
Following graduation, you will combine
your medical training with that of an officer in
the Canadian Forces.

6. Coprophilia.
a) attraction of microorganisms to fecal matter;
b) a psychiatric term denoting a morbid attraction and
interest in fecal matter;
c) the attractio n of s p e rm atoz oa to co ppe r- th e
principle behind copper wire intrauterine devices;
d ) (a) & (b).

7. Proemial.
a) a late occurrence of a disease process;
b) refer r ing to a n ea rl y s ta ge of e mbryologic
development;
c) prodromal;
d ) maliormation of the prosencephalon.

rl:l
b9J

For mo~ informatio n. visit your nea~st rttruiting
centre or call collec< - we're in the Yellow Pages••
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9. Trephination.
a) a long, hollow tube through which sounds are resonated
great distances;
b) the process of boring a hole in any flat bone, especially
the patella, to allow escape of pus;
c) a reconstructive surgical technique whereby a piece of
bone is remodelled;
d) removal of a circular peice of cranium by a trephine.
10.
a)
b)
c)

Hedrocoele.
accumulation of serous fluid in the tunica vaginalis testis;
a downward displacement of the caecum;
a small bullous rising of the skin which contains serous
fluid;
d) a hernia or porlapse through the anus.
11.
a)
b)
c)
d)

Bruxism.
clenching and grinding of teeth, usually during sleep;
spasm of masticatory muscles;
pain secondary to malocclusion of the teeth;
partial paralysis of the upper palate due to inferior
alveolar nerve damage.

12. Egilops.
a) a Freudian term referring to an unbalanced psyche;
b) an obsolete term fo r a swelling at the inner canthus of the
eye;
c) an inability to resist sexual impulses;
d) (a) & (c).

13. Progeria.
a) premature senility synd rome;
b) the syndrome of continuous endometrial sloughing due
to an absence of progesterone;
c) the constellation of signs and symptoms due to excess
progesterone-weight gain, headache, edema, and
depression;
d) the manifestion of infantile behaviours associated with
senile dementia.
14. Kerley Lines.
a) thickening of interlobular lung septa seen on a chest xray;
b) transverse folds of the mucous membrane of the small
bowel;
c) growth bands in the dentin of a tooth;
d) lines extending from the upper limit of the obturator
foramen to the middle of the neck of the femur, seen on
an x-ray of the hip.
15. Betel Nut.
a) the nut of the areca palm tree chewed by natives of the
East Indies;
b) an extract from the cytoskeleton of the South American
Piper Beetle-used as a soporific agent;
c) an Indian delicacy, derived from the giant red-haired
beetle, indiginous to the Himalaya mountains;
d) a slang indicating testicu lar inflammation; a condition
restricted to men with a hereditary deficiency of the
enzyme which metabolizes betacyanin, a byproduct of
beet ingestion.
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ANSWERS TO CASE STUDY
1. It appears this child is having an unusual problem with

2.

You don't want to learn that you're going
to be a parent before you're ready.
Or that through one careless moment,
you've caught an unwanted disease.

So take care. Be well informed and protect
yourself.
At Ortho, we're the experts in birth control
and disease prevention. That's why we'd
like to help make sure you learn oruy the
things you want to learn.

3.
4.

W Take care. Not chances.

5.

We're working for you.
'Ne represent Parke· Davis .. . a
company of more than 600 people
dedicated to your hea lth and
well·being.
We are the people who
dl"o'eloped and produce medications
that help to control epilepsy. 'Ne are
the ones who make cardiovascular
agents that help to give people with
hean disease a more promising future.
'Ne even make products that help you
rest more comfonably when you
come downwithacold.

You also may be haWf to know
that there's something exciting going
on in our laboratories right now that
we expect to be our greatest
contribution to your hea~hcare so
far. You'll be hearing about it very,
very soon.
Hen!'stoahulthierunada.
Here's toa healthier you .
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frequent infections and possibly drug intolerance to
SeptraR. If she has an immunodeficiency it may be
congenital or acquired.
Since congenital
immunodeficiencies may be familial, the parents
hould be asked whether there exists a family history
of recurrent infections. The majority of children with
AIDS were infected pre or perinatally by their mothers.
The maternal history of known HIV infection or
recurrent infections is especially pertinent.
Congenital immunodeficiencies may be part of
syndromes manifesting with dysmorphic features (eg.
DiGeorge Syndrome of micrognathia, brachial clefts
and congenital heart disease). Children with recurrent
or chronic infections may have persistent stimulation
of their reticuloendothelial system and thus display
hepatosplenomegaly
and I or
generalized
lymphadenopathy. They may also suffer signs of
persistent mucosal infections such as thrush
(Candidiasis) and herpetic lesions.
The history and physical examination are suggestive of
recurrent infections due to an underlying
immunodeficiency.
The immunodeficiencies can be categorized into T cell
disorders; B cell disorders; combined T and B cell
disorders; neutrophil and complement deficiencies.
These may be congenital or acquired. This child seems
to have been getting progressively worse since late
infancy, although the exact time of onset of an
abnormal frequency and severity of infections is
difficult to establish. A major clue is the open heart
urgery which invariably requires blood transfusions.
The Red Cross started screening blood products in the
Fall of 1985. Hence, this child was possibly exposed to
HIV contaminated blood and HIV infection should be
near the top of the differential diagnosis. Furthermore,
SeptraR intolerance is more common in HIV infected
patients.
A CBC and differential will indicate the numbers of
circulating neutrophils and lymphocytes, most of
which are T lumphocytes. However, the CD4 cells, a
subset of T lumphocytes which are usually decreased
in sy mptomatic HIV infections, may be severely
depressed in the presence of a normal circulating
lymphocyte count. Hence, the CD4 count should be
assessed specifically by flow cytometry. Her HIV
antibody status should be determined. Her total and
pecific immunoglobulin levels should also be
measured.
A CH 50 level which determines
complement activity is an appropriate screen for most
complement
deficiencies
resulting
in
immunosuppression. This child was found to be HIV
infected, had a low normal lymphocyte count and a
CD4 count of 400 which is below the normal level for
her age. Her immunoglobulin profile demonstrated
polyclonal stimulation with a marked increase in her

IgM.

. .. continued on page 54
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6. As one would expect, the aproach to a patient with
immunodeficiency is to treat the current opportunistic
infection with appropriate anti-infectives while
attem§.ting to correct the underlying disorder. The
Septra should be discontinued and if the impetiginous
lesions relapse they should be cultured. Cloxacillin
constitutes the antibiotic of choice since these infections
are u ually caused by Group A Streptococci and
Staphylococcus au reus. Oral ketoconazole or fluconazole is
usually required to treat mucosal candidia is in HIV
infected patients. Consideration should be given to
tarting anti-retroviral therapy ince the CD4 count is less
than 500.
Lastly, intravenous immunoglobulin is
recommended for chilfren with symptomatic HIV and
dysgammaglobulinernia to reduce the frequen cy and
severity of recurrent infections.
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ANSWERS TO VOCABULARY
Disease. (d) Heredopathia A tactica
Polyn euritiformis. A rare degenerative di s order
transmitted as an auto omal recessive trait and caused
by an absence of phytanic acid alpha-hydroxyla e. The
disease is characterized by retiniti pigmentosa,
polyneuritis, deafnes , nystagmus, and cerebellar igns.
2. Indolent. (b) Inactive; sluggish; painles or nearly sosaid of a morbid process.
3. Peristrumitis. (a) Inflammation of the tis ues around a
goitre.
4. Frottage. (c) The rubbin g movement in rna age;
production of sexual excitement by rubbing against
someone.
5. Oxyecoia. (d) An abnormal sensitivity to noises.
6. Coprophoelia. (d) Attraction of microorganisms to fecal
matter; In psychiatry, a morbid attraction to, and interest
in (with a sexual interest), fecal matter.
7. Proemial. (c) Prodromal; an early or premonitory
symptom of a disease.
8. Symphalangism. (b) Syndactyly; ankylosis of the finger
or toe joints.
9. Trephination. (d) Removal of a circular peice of cranium
by a trephine, a cylindrical or crow saw used for the
removal of a disc of bone, especially of the skull, or of
other firm tissue as that of the cornea.
10. Hedrocoele. (d) Prolapse of the intestine through the
anus.
11. Bruxism. (a) Clenching of the teeth, associated with
forceful lateral or protrusive jaw movements, resulting
in rubbing, gritting, or grinding together of the teeth,
usually during sleep.
12. Egilops. (b) Obsolete term for a swelling, absc ss, or
fistula at the inner canthus of the eye.
13. Progeria. (a) Hutchinson -Gilford Disease. Premature
senility syndrome; a condition in which normal
development in the first year is followed by gross
retardation of growth, with a senile appearance
characterized by dry, wrinkled skin, total alopecia, and
bird-like facies.
14. Kerley Lines. (a) Markings on chest roentgram
representing thickening of interlobular septa, due to
pulmonary edema or cellular infiltration.
15. Betel Nut. (a) Areca Nut. The nut of the areca palm
(Areca Catechu) chewed by natives of the East Indies; the
nut is so-called because it is chewed with dried Piper
Betle leaves (an East Indian red pepper plant used as a
stimulant and narcotic).
1. Refsum's

54

--be-dlhet>CIR* ...otorom.a.....,.,.,.c~osogemlhe- dE!do!w!lflonpy Theb e - not t o - ... doilr dosed 10 mg_ The nsk d usong 119101' doses d Bdo!w!l- be Olllllnd.llld
• bnot~dlhe'byportonsMcnsos" f choesaructJOn1 prowled

-

will--

Some pobents- ~may""'""""" .. ..,....., ......... d doporni1e reading

d lewclcl!>i iiSSOCated Side efteds. presooably '*"'to !he
be . . . .

post->yriOIIIJC .....,._Thest e!lects may"""'

Ill' rldo.ong !he dosed lewclcl!>i Ill' 111-30 perant
NIJRSII«l MOTifllS: I Gn o t - - 8do!w!l S ~ IIIUnlllllilt 8eause lllii1Y ~ ort ~ 111Un111
lliltaraBiiiJORS-beQMOtodisalnln.wlglheusedillbt.C-.."""'*1~-~~ 1115111-.

PEDIATRICUSf. Thre!lectsdEideprytr~cllldren...Wt811Mnotbeen~Tosll:

__....d-on

Nospdic lobcntDrytesiSort......,.lor
Eldepryt Trmsoenr or aJI1IIUng..........,. will
ln!Rylor--IIMrUDontesiSIIMbeendesailallllongterm""""'. Ahughsenous'-IDIOCIIy
hosnot--caDansS_II_will•"'*>ryd'-dysMc:tlon.- ...............
dillpi11811s5---

Dnll-

Thrcmmnced~ . -ngodily. SMI'ogamllld _
_.,...hosbeenreponool ll ''""'"'*""~~
seMgihllld . _ -, ,.,...,. _ _ , . _ ThestsympiOmSwere resoMd 1M1cloyswher1 !heCOII'IbNbon
was ciscor~Rmllls case is lj!lial d l h e - d ._me ll1d M.IQs. Oilier ltlllllhe tlCIR*- d Side
otfects 11 potJeniS receMr1Q lewclcl!>i flonpy, no
to lhe ,.,._used ELOEPRYL ll1d- ~
11M been "'II''Id- nis illso pn.dent to -lhe tornllrlillion d ELOEPRYlllld ~ (Prolx)

101er0C11onS-

Ull .... ,._.,.

--

The used 8do!w!l do.mg preoroncy !los not been-- Thertlore. Bdo!w!l- be gMOto •IQIIOIIIIW0111111
onlr i !he potentul- CIJiwo911he pol!rml nsks

A) IN
TOi WITH LEVOOOPA
111' SllE ffiKTS II' ElllEPRYl Nlf. USUAU YTHOSE ASSOCIATED WITH OOPAMINEIUliC EXaSS ElllEPRYl MAY
POTENTIATE 111' SIDE Efi£CTS II' LEVOOOPA. lii'RffORE AIUJSTM£NT II' 111' DOSAGE II' LEVOOOPA MAY Ill'
RfOUIRfO. ONE II' 111' MOST SERIOOS A1MRSE RE.ICT10NS REPORTED WITH EL!IEI'IlYL USED~ Nl AIUJNCT TO
LEVOOOPA 1IERAPY ARE HAllOONol~ PARTICLUAlYVISUAL HAWJCINATlONS

Ott.---.. . . .
8) IN IIONOTIERAPY

dimness.

tartness.---

dry

rnoulh.- ......... dyslanesas ll1d -

-

ThriiiCidonczd-.erudOIS"""""'"'IIINisusong~osrnortolherllpyhosnotbeenhAiy,_...,toclae.

Senous _ _ _ ........,cl1est_myopothyllld-Oiherrfi)OIIId-.e-""""""'----dilllness.llld..mgo_

-llypotensoon,-

kl pro51111ttMdinaiiNis, ... - . g - e!lects (istld .. decrusr1tl order d ltequency), ted to ! h e dEidepryl:-- hobiNtions.corWsm. depressm, tossd ballllce, - deLosions. ~- now or..,.....,
IliON pectons n . __E-..r1ts ~ed only rm1r os • cause oldisconlinuotion ol tr,.trnent ondude IIIXIOiy,
c~rowsonoss~tet............. dystonoo.IOCtUS!d ePsod<s d lreemQ. oncreosed tremor. wWr1ess. .......,.
CIOOSIIpOiion, weight toss,lunrlglips/l!ldl.----- -.gllldlwtoss.
~ ~ IIIOYOrrlll1ts, ogilobon, ontlylllmio. brodylonesa clloru.

'*"'".....,

n.-dosoged~osrnortolherllpyr~newly~pollr1IS.oros;diiJ'Citolewclcl!>i(USIIillrWIII1

• dealtlalylose ~ s 10 mg per c l o y - .. doses d 1M m g - - " - l l l d kn:ll
-ELDEI'IlYL,..._flonpyisocldedtolhetliiSIIIglewclcl!>o"""""'*regime·' -· USIIillrdiOIOJO

!hill-

pen:ent~lhedosedlewclcl!>i(~sornei1stonces•nDI:Iion~lhedosed~I0511'1Q/doy)maybereqwlddo.mg
lheperiodd__.d""""'or~cased-d-.ee!lects.Oosesligtor~tomgperdoy-nd

be 111111 T1W1 is n o -

benefil wl be -11om ! h e - d ligtor doses. Fwthetrnort,

h910fdoseswlr...-~.tossdselodMiyd~-MAG-8willi10nmst~lhe-dtypeii.IO-.\

_,
.....

11W1sllltrll:rl05ednsl<d-..,.-willh910fdosesaswelasllltrll:rl05ednskd""""""""epsodef clleese

-

Bdo!w!l5 m g - . . . - .. -d60tolllots.

t The -.son Study Group. Ellett d Oo!nn!t on 111e l'rogresslon d Oosollility 11 Eaty -..on·s Ooseose. New EnQ
...... 321 . 1364-1371 , 191!9. 2. ~ (seMgih ~~ Produd llonogniph. December 1990. 3.
lljtjloW, SolllliomKA. VUorinonJA. -E!lSIIeglneasinilll- llde....,pr11insonoi10-- Ne.ro10oY
19!12; 42. 339-343. 4. T - Jtl, l.lllgston ltl. The Efta:t d Oo!nn!t (Solegine) on 111e- Hislory d -..on·s
-.s-a,Augustt 91!9, wol245, 5 t~ S. IIjtjloW, Solllliom KA. VUorinonJ.II!ialnEKSIIeglne(~
aspoirr,.y-~ Pminson's-.Soleglneflonpy~ulrl'nnson'scisase.»t 1990. tH4.l ~NI
r~L.oosA.Or!nrl!t~Pminson'sOISeose:-lorctiniallls.North""""""fbnjla!JteSenos,No. I, 1!1118, t26. 7. ~RCIIl.oosA.Or!nrl!tr~Pminson'sOisase:-torCiiicin.NorthAmoriclllfbnjla!JieSenes.

No. I, 19118.1-26.

- - - - - - - - - - - - - - - - - - - - - - - - U. W .O. Medical Journal 63 (1) 1993

VITAMIN E UPDATE
Vitamin E (alpha-tocopherol) has
been the subject of many recent
publications that have attracted
much attention from both the
medical profession and the lay press.
Vitamin E, a primary lipid-soluble
antiox idant, is a membrane
consti tuent of the heart myocy te
where it plays an acive role in
counteri ng oxidative stress. In
addition, vitamin E may prevent the
oxidation of lipoproteins since the
atherogenic potential of 1 lipoproteins
increases when oxidized •
Vitamin E deficiency ma y be a
risk factor for heart disease. Further,
adequate levels of vitamin E may
prevent
the 2 progression of
atherosclerosis • Many current
studies are based on the hypothesis
that therapeutic vitamin E (or its
analogues) may protect the heart
3
from progressive ischemic injury ·•.
As well, research on peripheral
vasc ular disease indicates that
vitamin E may have a positive
effect
5
on intermittent claudication •
1 Free Radical Biology and Medicine. 11(1):129-44
(1991).
2 japanese journal of Clinical M edicine. 51(4):9971003 (I 993).
3 Canadian journal of Cardiology . 9(1) :89-93
(1993).
4 Free Radical Biology and Medicine. 10(5):315-24
(1991).
5 European ju orna l of Clinical Pharmacology.
37(6):541-4 (1989).

PBLPROP06ALPE~D

Newly appointed Associate
Dean Lloyd has released a
document proposing that the Faculty
of Medicine move to a PBL-based
curriculum. McMaster University,
Calgary, Toronto, Ottawa, and
Dalhousie now all have curricula
whose mainstay is PBL. Soon
classroom teaching could become a
thing of the past. As to whether or
not this new trend in teaching is
going to make a difference - well,
only time will tell.

SID E EFFECTS
CON CEALED FROM THIRD
WORLD PATIENTS
According to the current issue of
The New Physician (vo l 42(6):9), a
growing number of U .S.-based
m ultina tiona I
pharmaceutic a I
companies are selling drugs with
incomplete information labels to
developing countries. In a study
done by the U .S. Office of
Technology Assessment (OT A), twothirds of a random ample of 241
drugs failed to provide information
about the side effects of the drugs.
For example, one of the drugs being
sold overseas was an antiinflammatory drug that was taken
off the U.S. market because it caused
a fatal leukopenia . The OT A
suggests "the implementation of an
international code of conduct for
pharmaceutical labelling" to prevent
further abuses, since there are no
U .S. labelling laws encompassing
drugs being produced and marketed
by a foreign subsidiary of a U .S.
company.

BITTER TASTE IN YOUR
MOUTH?
The bitter taste of certain foods
and drugs may become a thing of the
past. A specific lipoprotein made of
phospha tidic
acid
and
ISlactoglobulin, abbreviated PA-LG,
reportedly binds to tongue receptors
for bitter substances. A high
concentration of PA-LG appears to
suppress the bitter taste sensation in
humans while leaving other taste
sensations unchanged. Phosphatidic
acid and IS-lactoglobulin are
produced from soya beans and milk
respectively. PA-LG may soon be
used to fight bitterness in taste buds
everywhere.
[Katsuragi et al., Nature. 365:213214 (1993).]

PARTICLE ACCELERATOR
TO FIGHT CANCER
Construction of the world's first
medical accelerator is nearing
completion in Japan. The 300 million
dollar
Heavy-Ion
Medical
Accelerator in Chiba (HIMAC) was
designed for use in cancer therapy.
HIMAC is expected to offer
cancer treatment programs by March
of 1994. Heavy-ion therapy involves
bombarding patients with an
assortment of ions like neon, carbon
and silicon.
Heavy ion therapy is gaining
interest for two reasons: First, the
mass and charge of heavy ions gives
these ions stronger tumourdestroying
capabilities
than
radiation therapy. Second, heavy ion
bombardment is more tumourspeciifc than radiation therapy. In
addition, aim of the charged ion
beam can be finely adjusted using
electromagnetic fields, and the ions
release most of their destructive
energy at the end of their path.
The disadvantages to this form of
therapy are high cost and rela tive
ineffectiveness against metastases.
HIMAC offers an alternate form
of cancer treatment with potentially
less side effects than present
treatment regimens.
[Science.
261:1270 (1993)]

BENEFITS OF SMOKING
IGNORED
Cigaretted smoking may be
protective for a number of diseases,
but reasearchers, granting agencies,
pharmaceutica l firms, and eth ics
comittees are reluctant to promote or
permit investigation into the area .
" People do not want to be seen to
promote smoking in any way, "
according to an article inNew
Scientist magazine. Nevertheless,
s ome evidence for benefits
attributable to smoking exists in
Parkinson's, Alzheimer's, ulcerative
colitis, rheumatoid arthritis, and
even some cancers!
[Mundell, I. New Scientist.
9 October 1993, pp. 14-15.]
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